<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: Source; Value: 211511 12312020 20F.xfr; Date: 2021%2D03%2D22T14:23:23Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80180002 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:IFRX="http://inflarx.com/20201231">
    <link:schemaRef xlink:href="ifrx-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ThirdPartyServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ThirdPartyServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ThirdPartyServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ThirdPartyServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LegalAndConsultingFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:LegalAndConsultingFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_LegalAndConsultingFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:LegalAndConsultingFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WagesAndSalariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:WagesAndSalariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_WagesAndSalariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:WagesAndSalariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrepaidExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PrepaidExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PrepaidExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PrepaidExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OtherAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_OtherAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ResearchAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ResearchAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_GeneralAndAdministrativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:GeneralAndAdministrativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_GeneralAndAdministrativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:GeneralAndAdministrativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ThirdPartyServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ThirdPartyServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_LegalAndConsultingFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:LegalAndConsultingFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_WagesAndSalariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:WagesAndSalariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ExecutiveManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:ExecutiveManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ExecutiveManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:ExecutiveManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:ExecutiveManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NonExecutiveBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:NonExecutiveBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_NonExecutiveBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:NonExecutiveBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:NonExecutiveBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_SharesOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:SharesOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ClinicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ClinicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ClinicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ClinicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ClinicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ClinicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ForeignExchangeIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:ForeignExchangeIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ForeignExchangeIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:ForeignExchangeIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_InterestIncomeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:InterestIncomeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_InterestIncomeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:InterestIncomeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InterestIncomeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:InterestIncomeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_MarketRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">ifrs-full:MarketRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_CreditRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LiquidityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">IFRX:LiquidityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_InflarxPharmaceuticalsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxPharmaceuticalsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_InflarxPharmaceuticalsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxPharmaceuticalsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SharebasedCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SharebasedCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SharebasedCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SharebasedCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SharebasedCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SharebasedCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_CostMember1811524294">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_BuildingsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BuildingsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AdvancePaymentsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AdvancePaymentsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_BuildingsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AdvancePaymentsMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AdvancePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AdvancePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">IFRX:AfterOneYearButNotMoreThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">IFRX:MoreThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_InflarxGmbHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxGmbHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_InflarxGmbHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxGmbHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:EquitySettledShareBasedPaymentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:EquitySettledShareBasedPaymentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:EquitySettledShareBasedPaymentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:EquitySettledShareBasedPaymentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EquitySettledShareBasedPaymentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:EquitySettledShareBasedPaymentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">IFRX:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_January1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:January1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_February4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:February4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_May14Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:May14Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RepricingJuly3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:RepricingJuly3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:RepricingJuly3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:RepricingJuly3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_October24Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:October24Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_December16No1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:December16No1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_December16No2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:December16No2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LaboratoryEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">IFRX:LaboratoryEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">IFRX:AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">IFRX:AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmployeeBenefitsExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:EmployeeBenefitsExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EmployeeBenefitsExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:EmployeeBenefitsExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EmployeeBenefitsExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:EmployeeBenefitsExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_InsuranceExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:InsuranceExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_InsuranceExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:InsuranceExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InsuranceExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:InsuranceExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_DepreciationAndAmortizationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationAndAmortizationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_DepreciationAndAmortizationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationAndAmortizationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_DepreciationAndAmortizationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationAndAmortizationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CompensationExpenseForNonExecutiveBoardDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CompensationExpenseForNonExecutiveBoardDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CompensationExpenseForNonExecutiveBoardDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CompensationExpenseForNonExecutiveBoardDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_CompensationExpenseForNonExecutiveBoardDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CompensationExpenseForNonExecutiveBoardDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ExpenseInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ExpenseInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ExpenseInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ExpenseInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ExpenseInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ExpenseInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_InterestOnLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:InterestOnLeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_InterestOnLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:InterestOnLeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InterestOnLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:InterestOnLeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ForeignExchangeIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:ForeignExchangeIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ForeignExchangeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ForeignExchangeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ForeignExchangeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ForeignExchangeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ForeignExchangeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ForeignExchangeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_September18No1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:September18No1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_September18No2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:September18No2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_October1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:October1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_October1Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:October1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_October1Member_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:October1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PropertyAndEquipmentMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_PropertyAndEquipmentMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PropertyAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PropertyAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PropertyAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_VehiclesMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_VehiclesMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_VehiclesMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:CostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AdvancesPaidForSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AdvancesPaidForSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:AdvancesPaidForSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrepaymentsOnResearchAndDevelopmentProjectsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PrepaymentsOnResearchAndDevelopmentProjectsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PrepaymentsOnResearchAndDevelopmentProjectsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PrepaymentsOnResearchAndDevelopmentProjectsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_USDollarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:USDollarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_USDollarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:USDollarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EuroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:EuroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EuroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:EuroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccountPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">IFRX:AccountPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccountPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">IFRX:AccountPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_OtherAccruedLiabilitiesAndPayablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">IFRX:OtherAccruedLiabilitiesAndPayablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_OtherAccruedLiabilitiesAndPayablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">IFRX:OtherAccruedLiabilitiesAndPayablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_GeneralAndAdministrativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:GeneralAndAdministrativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ResearchAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EuroWeakensMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:EuroWeakensMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EuroWeakensMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:EuroWeakensMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EuroStrengthensMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:EuroStrengthensMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EuroStrengthensMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:EuroStrengthensMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_GermanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">IFRX:GermanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_GermanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">IFRX:GermanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">IFRX:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">IFRX:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_NotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">IFRX:AfterOneYearButNotMoreThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MoreThanFiveYearsMember20658484">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">IFRX:MoreThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="EUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="EURPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:EUR</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="EURPerUSD">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:EUR</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Years">
      <xbrli:measure>utr:Y</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPerEUR">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>iso4217:EUR</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">InflaRx N.V.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001708688</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">20-F</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2020-01-01to2020-12-31">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityShellCompany>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-12-31">P7</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentAnnualReport contextRef="From2020-01-01to2020-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport contextRef="From2020-01-01to2020-12-31">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2020-01-01to2020-12-31">false</dei:DocumentShellCompanyReport>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">25684140</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">44582136</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">454193</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">898425</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_ThirdPartyServicesMember" unitRef="EUR" decimals="0">19886693</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_ThirdPartyServicesMember" unitRef="EUR" decimals="0">36783223</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="0">862364</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="0">668676</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">25028554</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">661065</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_ThirdPartyServicesMember" unitRef="EUR" decimals="0">15909366</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="0">421041</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_ManufacturingMember" unitRef="EUR" decimals="0">3075347</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_ManufacturingMember" unitRef="EUR" decimals="0">13479235</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_ManufacturingMember" unitRef="EUR" decimals="0">4828534</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_ClinicalMember" unitRef="EUR" decimals="0">16811346</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_ClinicalMember" unitRef="EUR" decimals="0">23303988</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_ClinicalMember" unitRef="EUR" decimals="0">11080832</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">626833</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">2580983</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">5256194</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_EmployeeBenefitsExpensesMember" unitRef="EUR" decimals="0">4480890</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_EmployeeBenefitsExpensesMember" unitRef="EUR" decimals="0">6231812</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_EmployeeBenefitsExpensesMember" unitRef="EUR" decimals="0">8037082</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">8467203</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">12501048</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">831769</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">1358587</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="0">1603711</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="0">2199640</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">12786869</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">897618</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="0">2020447</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">489958</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">4251227</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">6828457</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_EmployeeBenefitsExpensesMember" unitRef="EUR" decimals="0">3880349</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_EmployeeBenefitsExpensesMember" unitRef="EUR" decimals="0">7534073</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_EmployeeBenefitsExpensesMember" unitRef="EUR" decimals="0">9146955</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_InsuranceExpensesMember" unitRef="EUR" decimals="0">1311790</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_InsuranceExpensesMember" unitRef="EUR" decimals="0">636035</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_InsuranceExpensesMember" unitRef="EUR" decimals="0">368339</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_DepreciationAndAmortizationExpenseMember" unitRef="EUR" decimals="0">556456</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_DepreciationAndAmortizationExpenseMember" unitRef="EUR" decimals="0">503683</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_DepreciationAndAmortizationExpenseMember" unitRef="EUR" decimals="0">115330</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_CompensationExpenseForNonExecutiveBoardDirectorsMember" unitRef="EUR" decimals="0">283128</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_CompensationExpenseForNonExecutiveBoardDirectorsMember" unitRef="EUR" decimals="0">269030</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_CompensationExpenseForNonExecutiveBoardDirectorsMember" unitRef="EUR" decimals="0">238180</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OperatingExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">34151343</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">57083184</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">37815422</ifrs-full:OperatingExpense>
    <ifrs-full:OtherIncome contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">221748</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">400253</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">303860</ifrs-full:OtherIncome>
    <ifrs-full:OtherExpenseByNature contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">13209</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">85242</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">4802</ifrs-full:OtherExpenseByNature>
    <IFRX:OperatingResult contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-33942804</IFRX:OperatingResult>
    <IFRX:OperatingResult contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-56768173</IFRX:OperatingResult>
    <IFRX:OperatingResult contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-37516364</IFRX:OperatingResult>
    <ifrs-full:FinanceIncome contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">887702</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">2840676</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">2182842</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2020-01-01to2020-12-31_custom_InterestIncomeeMember" unitRef="EUR" decimals="0">887702</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2019-01-01to2019-12-31_custom_InterestIncomeeMember" unitRef="EUR" decimals="0">2840676</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2018-01-01to2018-12-31_custom_InterestIncomeeMember" unitRef="EUR" decimals="0">2182842</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">26000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">22265</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">0</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2020-01-01to2020-12-31_custom_ExpenseInterestMember" unitRef="EUR" decimals="0">18689</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2019-01-01to2019-12-31_custom_ExpenseInterestMember" unitRef="EUR" decimals="0">9500</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2018-01-01to2018-12-31_custom_ExpenseInterestMember" unitRef="EUR" decimals="0">0</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2020-01-01to2020-12-31_custom_InterestOnLeaseLiabilitiesMember" unitRef="EUR" decimals="0">7311</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2019-01-01to2019-12-31_custom_InterestOnLeaseLiabilitiesMember" unitRef="EUR" decimals="0">12765</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2018-01-01to2018-12-31_custom_InterestOnLeaseLiabilitiesMember" unitRef="EUR" decimals="0">0</ifrs-full:FinanceCosts>
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-33983614</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-53254817</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-53254817</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-33983614</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-29814634</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-29814634</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2019-01-01to2019-12-31_custom_SharesOutstandingMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2020-01-01to2020-12-31_custom_SharesOutstandingMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_custom_SharesOutstandingMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:AdjustedWeightedAverageShares contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">27064902</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">26004519</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">25095027</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare contextRef="From2020-01-01to2020-12-31" unitRef="EURPShares" decimals="INF">-1.26</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare contextRef="From2019-01-01to2019-12-31" unitRef="EURPShares" decimals="INF">-2.05</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare contextRef="From2018-01-01to2018-12-31" unitRef="EURPShares" decimals="INF">-1.19</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-5954019</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">2177033</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">50196</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:ComprehensiveIncome contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-39937633</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-51077785</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2019-01-01to2019-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-53254817</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2020-01-01to2020-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-33983614</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-29764438</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2018-01-01to2018-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-29814634</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2019-01-01to2019-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">2177033</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2020-01-01to2020-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">-5954019</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">50196</ifrs-full:ComprehensiveIncome>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2020-12-31" unitRef="EUR" id="Foot-00-0" decimals="0">408263</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2019-12-31" unitRef="EUR" id="Foot-00-1" decimals="0">576373</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2020-12-31_custom_AdvancePaymentsMember" unitRef="EUR" decimals="0">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2019-12-31_custom_AdvancePaymentsMember" unitRef="EUR" decimals="0">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2020-12-31_custom_PropertyAndEquipmentMember" unitRef="EUR" decimals="0">408263</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2019-12-31_custom_PropertyAndEquipmentMember" unitRef="EUR" decimals="0">576372</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">350183</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">452400</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember" unitRef="EUR" decimals="0">350184</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember" unitRef="EUR" decimals="0">444210</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2020-12-31_custom_AdvancesPaidForSoftwareMember" unitRef="EUR" decimals="0">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2019-12-31_custom_AdvancesPaidForSoftwareMember" unitRef="EUR" decimals="0">8190</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">353522</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">452217</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="AsOf2020-12-31_custom_PrepaidExpensesMember" unitRef="EUR" decimals="0">353522</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="AsOf2019-12-31_custom_PrepaidExpensesMember" unitRef="EUR" decimals="0">452217</ifrs-full:OtherNoncurrentNonfinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">272268</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">272614</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">1930930</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">2590528</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2020-12-31_custom_GermanyMember" unitRef="EUR" decimals="0">1712000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2019-12-31_custom_GermanyMember" unitRef="EUR" decimals="0">2217000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2020-12-31_custom_UnitedStatesMember" unitRef="EUR" decimals="0">219000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2019-12-31_custom_UnitedStatesMember" unitRef="EUR" decimals="0">374000</ifrs-full:NoncurrentAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" id="Foot-00-2" decimals="0">3734700</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" id="Foot-00-3" decimals="0">2365916</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2020-12-31_custom_PrepaidExpensesMember" unitRef="EUR" decimals="0">1295682</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2019-12-31_custom_PrepaidExpensesMember" unitRef="EUR" decimals="0">1467936</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2020-12-31_ifrs-full_OtherAssetsMember" unitRef="EUR" decimals="0">98374</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2019-12-31_ifrs-full_OtherAssetsMember" unitRef="EUR" decimals="0">199088</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2020-12-31_custom_PrepaymentsOnResearchAndDevelopmentProjectsMember" unitRef="EUR" decimals="0">2340643</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2019-12-31_custom_PrepaymentsOnResearchAndDevelopmentProjectsMember" unitRef="EUR" decimals="0">698891</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:CurrentFinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">55162033</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:CurrentFinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">82353867</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">25968681</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">33131280</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2018-12-31" unitRef="EUR" decimals="0">55386240</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2017-12-31" unitRef="EUR" decimals="0">123281888</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">86284904</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">118986031</ifrs-full:CurrentAssets>
    <ifrs-full:Assets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">88215834</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">121576558</ifrs-full:Assets>
    <ifrs-full:IssuedCapital contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">3387410</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">3132631</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">220289876</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">211006606</ifrs-full:SharePremium>
    <ifrs-full:OtherReserves contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">26259004</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">25142213</ifrs-full:OtherReserves>
    <ifrs-full:RetainedEarnings contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">-168345620</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">-134362006</ifrs-full:RetainedEarnings>
    <IFRX:OtherComponentsOfEquity contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">-3726791</IFRX:OtherComponentsOfEquity>
    <IFRX:OtherComponentsOfEquity contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">2227228</IFRX:OtherComponentsOfEquity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">77863880</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">107146673</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">3115725</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">3132631</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">3387410</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-81107188</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-134362006</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-168345620</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31" unitRef="EUR" decimals="0">151390571</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">18310003</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">25142213</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">26259004</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">2857452</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">6225353</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="0">-51292555</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31" unitRef="EUR" decimals="0">119428816</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">211021835</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">211006606</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">220289876</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">161638566</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">50196</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">2227228</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">-3726791</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">0</ifrs-full:Equity>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">220525</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">330745</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">33323</ifrs-full:OtherNoncurrentNonfinancialLiabilities>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">39013</ifrs-full:OtherNoncurrentNonfinancialLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">253847</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">369758</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">338516</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">515203</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">1368731</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">975629</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:Provisions contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">15000</ifrs-full:Provisions>
    <ifrs-full:Provisions contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">50000</ifrs-full:Provisions>
    <ifrs-full:CurrentLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">10098107</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">14060128</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">10351954</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">14429886</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">88215834</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">121576558</ifrs-full:EquityAndLiabilities>
    <ifrs-full:NumberOfSharesOutstanding contextRef="AsOf2018-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">25964379</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding contextRef="AsOf2019-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">26105255</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding contextRef="AsOf2020-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">28228415</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding contextRef="AsOf2017-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">23812100</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-5954019</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">2177033</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">50196</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2019-01-01to2019-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">2177033</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2020-01-01to2020-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">-5954019</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="0">50196</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <IFRX:IssueOfShareCapitalShares contextRef="From2020-01-01to2020-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">1958186</IFRX:IssueOfShareCapitalShares>
    <IFRX:IssueOfShareCapitalShares contextRef="From2018-01-01to2018-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">1850000</IFRX:IssueOfShareCapitalShares>
    <IFRX:IssueOfShareCapital contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">9770943</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2020-01-01to2020-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">234982</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">52990733</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">222000</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2020-01-01to2020-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">9535961</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">52768733</IFRX:IssueOfShareCapital>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-729840</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-3801265</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2020-01-01to2020-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">-729840</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">-3801265</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">1116791</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">6832210</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">12084651</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2019-01-01to2019-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">6832210</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2020-01-01to2020-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">1116791</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="0">12084651</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:IncreaseDecreaseThroughExerciseOfOptionsShares contextRef="From2019-01-01to2019-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">140876</IFRX:IncreaseDecreaseThroughExerciseOfOptionsShares>
    <IFRX:IncreaseDecreaseThroughExerciseOfOptionsShares contextRef="From2020-01-01to2020-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">164974</IFRX:IncreaseDecreaseThroughExerciseOfOptionsShares>
    <IFRX:IncreaseDecreaseThroughExerciseOfOptionsShares contextRef="From2018-01-01to2018-12-31_custom_SharesOutstandingMember" unitRef="Shares" decimals="INF">302279</IFRX:IncreaseDecreaseThroughExerciseOfOptionsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">496946</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">1676</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2019-01-01to2019-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">16905</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2020-01-01to2020-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">19797</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">452075</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="0">36273</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2019-01-01to2019-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">-15229</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2020-01-01to2020-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">477149</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="0">415801</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:ProfitLossBeforeTax contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-33983614</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-53254817</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-29814634</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">712713</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">663166</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">173630</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-40810</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">3513355</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">7701731</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">1116791</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">6832210</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">12084651</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">3436</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">60628</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">213956</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">0</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">0</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-316112</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">355545</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">235500</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">494837</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-4155529</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">5734795</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">2243137</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">1201547</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">3001109</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">1679250</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">26387</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">20903</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">0</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-36527661</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-43204492</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-21549248</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">94189</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">594889</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">806531</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <IFRX:PurchaseOfInvestmentsInNoncurrentFinancialAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">0</IFRX:PurchaseOfInvestmentsInNoncurrentFinancialAssets>
    <IFRX:PurchaseOfInvestmentsInNoncurrentFinancialAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">75543</IFRX:PurchaseOfInvestmentsInNoncurrentFinancialAssets>
    <IFRX:PurchaseOfInvestmentsInNoncurrentFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">209705</IFRX:PurchaseOfInvestmentsInNoncurrentFinancialAssets>
    <IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">0</IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets>
    <IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">0</IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets>
    <IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">21811</IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">21361982</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">20341554</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-99449341</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <IFRX:IssuedShareCapital contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-9770944</IFRX:IssuedShareCapital>
    <IFRX:IssuedShareCapital contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">0</IFRX:IssuedShareCapital>
    <IFRX:IssuedShareCapital contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-52990733</IFRX:IssuedShareCapital>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">496946</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">1676</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">452075</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">366156</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">296020</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">0</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">9171893</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-294344</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">49641542</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-5993786</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-23157282</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-71357047</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">8361239</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">13765885</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2020-01-01to2020-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">421887</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2019-01-01to2019-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">396613</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2020-01-01to2020-12-31_custom_WagesAndSalariesMember" unitRef="EUR" decimals="0">6270757</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2019-01-01to2019-12-31_custom_WagesAndSalariesMember" unitRef="EUR" decimals="0">5974807</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2020-01-01to2020-12-31_custom_SocialSecurityMember" unitRef="EUR" decimals="0">551804</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2019-01-01to2019-12-31_custom_SocialSecurityMember" unitRef="EUR" decimals="0">562255</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">17184037</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="0">247522</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_WagesAndSalariesMember" unitRef="EUR" decimals="0">4501840</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_SocialSecurityMember" unitRef="EUR" decimals="0">350024</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2020-01-01to2020-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">1116791</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2019-01-01to2019-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">6832210</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_SharebasedCompensationExpenseMember" unitRef="EUR" decimals="0">12084651</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:FinanceIncomeCost contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">861702</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">2818411</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">2182842</ifrs-full:FinanceIncomeCost>
    <IFRX:TaxLossCarryforward contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">148900000</IFRX:TaxLossCarryforward>
    <IFRX:TaxLossCarryforward contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">114400000</IFRX:TaxLossCarryforward>
    <ifrs-full:ApplicableTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">.2870</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">.2960</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">.2910</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">9761910</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">15815083</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">8715116</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-9761910</IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized>
    <IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-15815083</IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized>
    <IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-8715116</IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">692081</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">719593</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2018-12-31_custom_CostMember" unitRef="EUR" decimals="0">356204</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2019-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">-239681</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2020-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">-369410</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2018-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">-133337</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">683891</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">719593</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">246351</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">8190</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2018-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">109852</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">-239681</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">-369410</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">-133337</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsBalance>
    <IFRX:IntangibleAssetsBalance contextRef="AsOf2018-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsBalance>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="From2020-01-01to2020-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">129963</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="From2019-01-01to2019-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">106358</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">129963</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">106358</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</ifrs-full:AdjustmentsForAmortisationExpense>
    <IFRX:IntangibleAssetsAdditions contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">28075</IFRX:IntangibleAssetsAdditions>
    <IFRX:IntangibleAssetsAdditions contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">335942</IFRX:IntangibleAssetsAdditions>
    <IFRX:IntangibleAssetsAdditions contextRef="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">28075</IFRX:IntangibleAssetsAdditions>
    <IFRX:IntangibleAssetsAdditions contextRef="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">84449</IFRX:IntangibleAssetsAdditions>
    <IFRX:IntangibleAssetsAdditions contextRef="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsAdditions>
    <IFRX:IntangibleAssetsAdditions contextRef="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">251493</IFRX:IntangibleAssetsAdditions>
    <IFRX:IntangibleAssetsReclassifications contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsReclassifications>
    <IFRX:IntangibleAssetsReclassifications contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsReclassifications>
    <IFRX:IntangibleAssetsReclassifications contextRef="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">8190</IFRX:IntangibleAssetsReclassifications>
    <IFRX:IntangibleAssetsReclassifications contextRef="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">353155</IFRX:IntangibleAssetsReclassifications>
    <IFRX:IntangibleAssetsReclassifications contextRef="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">-8190</IFRX:IntangibleAssetsReclassifications>
    <IFRX:IntangibleAssetsReclassifications contextRef="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">-353155</IFRX:IntangibleAssetsReclassifications>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">-562</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">-64</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">234</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_AmortizationMember" unitRef="EUR" decimals="0">14</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">-562</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">-64</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">234</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_ifrs-full_ComputerSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">14</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsExchangeDifferences>
    <IFRX:IntangibleAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_AdvancesPaidForSoftwareMember_custom_AmortizationMember" unitRef="EUR" decimals="0">0</IFRX:IntangibleAssetsExchangeDifferences>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" id="Foot-01-0" decimals="0">362137</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" id="Foot-02-0" decimals="0">265957</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" id="Foot-02-1" decimals="0">0</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-335608</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-370018</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-283350</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-304181</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-34410</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-20831</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" id="Foot-01-1" decimals="0">7311</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" id="Foot-02-2" decimals="0">12765</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" id="Foot-02-3" decimals="0">0</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:RentalExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" id="Foot-01-2" decimals="0">6275</ifrs-full:RentalExpense>
    <ifrs-full:RentalExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" id="Foot-02-4" decimals="0">70451</ifrs-full:RentalExpense>
    <ifrs-full:RentalExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" id="Foot-02-5" decimals="0">213200</ifrs-full:RentalExpense>
    <IFRX:ShortTermLeases contextRef="From2020-01-01to2020-12-31" unitRef="EUR" id="Foot-01-3" decimals="0">937</IFRX:ShortTermLeases>
    <IFRX:ShortTermLeases contextRef="From2019-01-01to2019-12-31" unitRef="EUR" id="Foot-02-6" decimals="0">65348</IFRX:ShortTermLeases>
    <IFRX:ShortTermLeases contextRef="From2018-01-01to2018-12-31" unitRef="EUR" id="Foot-02-7" decimals="0">0</IFRX:ShortTermLeases>
    <IFRX:LeaseOfLowValueAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" id="Foot-01-4" decimals="0">5338</IFRX:LeaseOfLowValueAssets>
    <IFRX:LeaseOfLowValueAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" id="Foot-02-8" decimals="0">5103</IFRX:LeaseOfLowValueAssets>
    <IFRX:LeaseOfLowValueAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" id="Foot-02-9" decimals="0">0</IFRX:LeaseOfLowValueAssets>
    <IFRX:TotalAmountsRecognizedInProfitOrLoss contextRef="From2020-01-01to2020-12-31" unitRef="EUR" id="Foot-01-5" decimals="0">375723</IFRX:TotalAmountsRecognizedInProfitOrLoss>
    <IFRX:TotalAmountsRecognizedInProfitOrLoss contextRef="From2019-01-01to2019-12-31" unitRef="EUR" id="Foot-02-10" decimals="0">349173</IFRX:TotalAmountsRecognizedInProfitOrLoss>
    <IFRX:TotalAmountsRecognizedInProfitOrLoss contextRef="From2018-01-01to2018-12-31" unitRef="EUR" id="Foot-02-11" decimals="0">213200</IFRX:TotalAmountsRecognizedInProfitOrLoss>
    <ifrs-full:OtherNonfinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">4088221</ifrs-full:OtherNonfinancialAssets>
    <ifrs-full:OtherNonfinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">2818132</ifrs-full:OtherNonfinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">272268</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">272614</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">8258133</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">12413662</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2020-12-31_custom_AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember" unitRef="EUR" decimals="0">5250654</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2019-12-31_custom_AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember" unitRef="EUR" decimals="0">8274042</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2020-12-31_custom_AccountPayableMember" unitRef="EUR" decimals="0">1741251</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2019-12-31_custom_AccountPayableMember" unitRef="EUR" decimals="0">3351100</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2020-12-31_custom_OtherAccruedLiabilitiesAndPayablesMember" unitRef="EUR" decimals="0">1266228</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2019-12-31_custom_OtherAccruedLiabilitiesAndPayablesMember" unitRef="EUR" decimals="0">788520</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">24416767</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">27803153</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2020-12-31_custom_USDollarMember" unitRef="EUR" decimals="0">22616767</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2019-12-31_custom_USDollarMember" unitRef="EUR" decimals="0">27803153</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2020-12-31_custom_EuroMember" unitRef="EUR" decimals="0">1800000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2019-12-31_custom_EuroMember" unitRef="EUR" decimals="0">0</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">1551914</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">5328127</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <IFRX:MarketableSecuritiesTotal contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">54752700</IFRX:MarketableSecuritiesTotal>
    <IFRX:MarketableSecuritiesTotal contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">81895377</IFRX:MarketableSecuritiesTotal>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">409333</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">458491</ifrs-full:OtherCurrentFinancialAssets>
    <IFRX:FundsAvailable contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">81402982</IFRX:FundsAvailable>
    <IFRX:FundsAvailable contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">115757762</IFRX:FundsAvailable>
    <ifrs-full:CreditExposure contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">81400000</ifrs-full:CreditExposure>
    <ifrs-full:CreditExposure contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">115800000</ifrs-full:CreditExposure>
    <ifrs-full:CountryOfIncorporation contextRef="From2020-01-01to2020-12-31_custom_InflarxPharmaceuticalsIncMember">U.S.</ifrs-full:CountryOfIncorporation>
    <ifrs-full:CountryOfIncorporation contextRef="From2020-01-01to2020-12-31_custom_InflarxGmbHMember">Germany</ifrs-full:CountryOfIncorporation>
    <ifrs-full:DescriptionOfFunctionalCurrency contextRef="From2020-01-01to2020-12-31_custom_InflarxPharmaceuticalsIncMember">USD</ifrs-full:DescriptionOfFunctionalCurrency>
    <ifrs-full:DescriptionOfFunctionalCurrency contextRef="From2020-01-01to2020-12-31_custom_InflarxGmbHMember">EUR</ifrs-full:DescriptionOfFunctionalCurrency>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2020-01-01to2020-12-31_custom_InflarxPharmaceuticalsIncMember" unitRef="Percent" decimals="INF">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2019-01-01to2019-12-31_custom_InflarxPharmaceuticalsIncMember" unitRef="Percent" decimals="INF">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2020-01-01to2020-12-31_custom_InflarxGmbHMember" unitRef="Percent" decimals="INF">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2019-01-01to2019-12-31_custom_InflarxGmbHMember" unitRef="Percent" decimals="INF">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities contextRef="From2020-01-01to2020-12-31_custom_InflarxPharmaceuticalsIncMember">Subsidiary for basic research</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities contextRef="From2020-01-01to2020-12-31_custom_InflarxGmbHMember">Principal operating subsidiary, biopharmaceutical company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2019-01-01to2019-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">2793529</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2020-01-01to2020-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">1995292</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">2524202</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2019-01-01to2019-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">269031</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2020-01-01to2020-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">283127</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">238180</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2019-01-01to2019-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">5218324</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2020-01-01to2020-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">1139286</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">9801454</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2019-01-01to2019-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">710611</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2020-01-01to2020-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">69938</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">1085917</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">3487643</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">8991495</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">13649754</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2019-01-01to2019-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">8011853</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2020-01-01to2020-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">3134578</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="0">12325656</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2019-01-01to2019-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">979642</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2020-01-01to2020-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">353065</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="0">1324098</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">148433</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">148433</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">289309</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1181484</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1094852</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1181484</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">2181105</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">2146478</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">2051009</ifrs-full:NumberOfOutstandingShareOptions>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-0" decimals="INF">0.01</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-1" decimals="INF">0.01</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2018-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-2" decimals="INF">0.01</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-6" decimals="INF">2.98</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-7" decimals="INF">2.73</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2018-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-8" decimals="INF">7.81</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-9" decimals="INF">3.06</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-10" decimals="INF">2.93</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement contextRef="AsOf2018-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-11" decimals="INF">3.16</IFRX:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement contextRef="From2020-01-01to2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-3" decimals="INF">.00</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement contextRef="From2019-01-01to2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-4" decimals="INF">0.01</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-12" decimals="INF">2.94</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-13" decimals="INF">.00</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-14" decimals="INF">2.94</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-15" decimals="INF">.00</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentsArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">148433</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">148433</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1181484</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1094852</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">1319548</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">1863790</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement contextRef="AsOf2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-5" decimals="INF">0.01</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement contextRef="AsOf2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="EURPShares" id="Foot-03-6" decimals="INF">0.01</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement contextRef="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-16" decimals="INF">2.98</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement contextRef="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="EURPShares" id="Foot-01-17" decimals="INF">2.73</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement contextRef="AsOf2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-18" decimals="INF">3.13</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement contextRef="AsOf2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-19" decimals="INF">2.82</IFRX:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentsArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-20" decimals="INF">3.17</IFRX:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentsArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-21" decimals="INF">5.51</IFRX:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentsArrangement>
    <IFRX:ShareOptionsOutstanding contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">246188</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">242450</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="Shares" decimals="INF">0</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="Shares" decimals="INF">18450</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="Shares" decimals="INF">36000</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member" unitRef="Shares" decimals="INF">0</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="Shares" decimals="INF">50000</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="Shares" decimals="INF">38000</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="Shares" id="Foot-04-0" decimals="INF">100000</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="Shares" decimals="INF">71186</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="Shares" decimals="INF">25002</IFRX:ShareOptionsOutstanding>
    <IFRX:ShareOptionsOutstanding contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="Shares" decimals="INF">150000</IFRX:ShareOptionsOutstanding>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="USDPShares" decimals="INF">14.45</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="USDPShares" decimals="INF">18.17</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="USDPShares" decimals="INF">22.54</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.46</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.08</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="USDPShares" decimals="INF">1.96</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="USDPShares" decimals="INF">3.07</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="USDPShares" decimals="INF">3.07</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="USDPShares" decimals="INF">4.16</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="USDPShares" decimals="INF">4.21</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="USDPShares" decimals="INF">3.69</IFRX:FairValuePerOptionUSD>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="EURPerUSD" decimals="INF">0.88</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="EURPerUSD" decimals="INF">0.87</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="EURPerUSD" decimals="INF">0.89</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member" unitRef="EURPerUSD" decimals="INF">0.89</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="EURPerUSD" decimals="INF">0.90</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="EURPerUSD" decimals="INF">0.90</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="EURPerUSD" decimals="INF">0.90</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="EURPerUSD" decimals="INF">.85</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="EURPerUSD" decimals="INF">.85</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="EURPerUSD" decimals="INF">.85</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="EURPShares" decimals="INF">12.69</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="EURPShares" decimals="INF">15.87</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="EURPShares" decimals="INF">20.08</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MinimumMember" unitRef="EURPShares" decimals="INF">0.40</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MaximumMember" unitRef="EURPShares" decimals="INF">0.96</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="EURPShares" decimals="INF">1.76</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="EURPShares" decimals="INF">2.75</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="EURPShares" decimals="INF">2.75</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="EURPShares" decimals="INF">3.52</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="EURPShares" decimals="INF">3.56</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="EURPShares" decimals="INF">3.14</IFRX:FairValuePerOptionEUR>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="USDPShares" decimals="INF">26.02</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="USDPShares" decimals="INF">32.63</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="USDPShares" decimals="INF">41.39</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member" unitRef="USDPShares" decimals="INF">3.35</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="USDPShares" decimals="INF">2.28</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="USDPShares" decimals="INF">3.57</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="USDPShares" decimals="INF">3.57</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="USDPShares" decimals="INF">4.83</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="USDPShares" decimals="INF">4.83</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2020-01-01to2020-12-31_custom_October1Member_srt_MinimumMember" unitRef="USDPShares" decimals="INF">4.28</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2020-01-01to2020-12-31_custom_October1Member_srt_MaximumMember" unitRef="USDPShares" decimals="INF">4.83</IFRX:SharePriceAtGrantDateUSD>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="Percent" decimals="INF">.65</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="Percent" decimals="INF">.65</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="Percent" decimals="INF">.65</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="Percent" decimals="INF">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="Years" decimals="INF">4.80</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="Years" decimals="INF">4.90</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="Years" decimals="INF">4.70</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MinimumMember" unitRef="Years" decimals="INF">2.30</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member_srt_MaximumMember" unitRef="Years" decimals="INF">4.60</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="Years" decimals="INF">4.70</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="Years" decimals="INF">4.70</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="Years" decimals="INF">4.70</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="Years" decimals="INF">4.8</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="Years" decimals="INF">5.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="Years" decimals="INF">5.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_January1Member" unitRef="Percent" decimals="INF">0.0300</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_February4Member" unitRef="Percent" decimals="INF">0.0260</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_May14Member" unitRef="Percent" decimals="INF">0.0230</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_RepricingJuly3Member" unitRef="Percent" decimals="INF">0.0230</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_October24Member" unitRef="Percent" decimals="INF">0.0165</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_December16No1Member" unitRef="Percent" decimals="INF">0.0179</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2019-01-01to2019-12-31_custom_December16No2Member" unitRef="Percent" decimals="INF">0.0179</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_September18No1Member" unitRef="Percent" decimals="INF">.0036</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_September18No2Member" unitRef="Percent" decimals="INF">.0039</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2020-01-01to2020-12-31_custom_October1Member" unitRef="Percent" decimals="INF">.0036</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:OtherFinanceIncomeCost contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-126000</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">0</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-107182</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-776512</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">694944</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">5626071</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2019-01-01to2019-12-31_custom_ForeignExchangeIncomeMember" unitRef="EUR" decimals="0">3379644</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2018-01-01to2018-12-31_custom_ForeignExchangeIncomeMember" unitRef="EUR" decimals="0">8249853</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2020-01-01to2020-12-31_custom_ForeignExchangeIncomeMember" unitRef="EUR" decimals="0">3656922</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2020-01-01to2020-12-31_custom_ForeignExchangeExpenseMember" unitRef="EUR" decimals="0">-4433435</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2019-01-01to2019-12-31_custom_ForeignExchangeExpenseMember" unitRef="EUR" decimals="0">-2684700</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="From2018-01-01to2018-12-31_custom_ForeignExchangeExpenseMember" unitRef="EUR" decimals="0">-2623782</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:RightofuseAssets contextRef="AsOf2020-12-31" unitRef="EUR" id="Foot-00-4" decimals="0">546694</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="AsOf2019-12-31" unitRef="EUR" id="Foot-00-5" decimals="0">836924</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="AsOf2019-12-31_ifrs-full_BuildingsMember" unitRef="EUR" decimals="0">822697</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="AsOf2020-12-31_ifrs-full_BuildingsMember" unitRef="EUR" decimals="0">485369</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="AsOf2020-12-31_ifrs-full_VehiclesMember" unitRef="EUR" decimals="0">61324</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="AsOf2019-12-31_ifrs-full_VehiclesMember" unitRef="EUR" decimals="0">14227</ifrs-full:RightofuseAssets>
    <ifrs-full:CurrentTaxAssets contextRef="AsOf2020-12-31" unitRef="EUR" id="Foot-00-6" decimals="0">1419490</ifrs-full:CurrentTaxAssets>
    <ifrs-full:CurrentTaxAssets contextRef="AsOf2019-12-31" unitRef="EUR" id="Foot-00-7" decimals="0">1134968</ifrs-full:CurrentTaxAssets>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">8258133</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">12413662</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2020-12-31_custom_AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember" unitRef="EUR" decimals="0">5250654</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2019-12-31_custom_AccruedLiabilitiesFromResearchAndDevelopmentProjectsMember" unitRef="EUR" decimals="0">8274042</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">117727</ifrs-full:OtherCurrentNonfinancialLiabilities>
    <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">105634</ifrs-full:OtherCurrentNonfinancialLiabilities>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-247322</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-368477</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-17257</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">8960</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-209948</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">304627</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-1554611</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-2364399</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">-893602</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <IFRX:PurchaseOfCurrentFinancialAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">101600176</IFRX:PurchaseOfCurrentFinancialAssets>
    <IFRX:PurchaseOfCurrentFinancialAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">82547409</IFRX:PurchaseOfCurrentFinancialAssets>
    <IFRX:PurchaseOfCurrentFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">106445120</IFRX:PurchaseOfCurrentFinancialAssets>
    <ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">123056347</ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets>
    <ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">103559395</ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets>
    <ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">7990204</ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-1168813</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">902321</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">3461399</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated financial statements&#13;of InflaRx N.V. and its subsidiaries (collectively, the &amp;#8216;Group&amp;#8217;) for the year ended December 31, 2020 were authorized&#13;for issue in accordance with a resolution of the Board of Directors on March 24, 2021. InflaRx N.V. (the &amp;#8216;Company&amp;#8217;)&#13;is a Dutch public company with limited liability (naamloze vennootschap) with its corporate seat in Amsterdam, The Netherlands,&#13;and is registered in the Commercial Register of The Netherlands Chamber of Commerce Business Register under CCI number 68904312.&#13;The Company&amp;#8217;s registered office is at Winzerlaer Stra&amp;#223;e 2 in 07745 Jena, Germany. Since November 10, 2017, InflaRx N.V.&amp;#8217;s&#13;common shares have been listed on the NASDAQ Global Select Market under the symbol &amp;#8220;IFRX&amp;#8221;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;InflaRx N.V. and its subsidiaries are&#13;a clinical-stage biopharmaceutical Group focused on applying its proprietary anti-C5a technology to discover and develop first-in-class,&#13;potent and specific inhibitors of the complement activation factor known as C5a.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Subsidiaries are all entities over which&#13;the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement&#13;with the entity and could affect those returns through its power to direct the activities of the entity. Subsidiaries are fully&#13;consolidated from the date on which control is obtained by the Group. They are deconsolidated from the date control ceases. The&#13;acquisition method of accounting is used to account for business combinations by the Group. Intercompany transactions, balances&#13;and unrealized gains on transactions between Group companies are eliminated. Unrealized losses are also eliminated unless the transaction&#13;provides evidence of an impairment of the transferred asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s subsidiaries at December&#13;31, 2020 are set out below. Unless otherwise stated, they have share capital consisting solely of common shares that are held directly&#13;by the Company, and the proportion of ownership interests held equals the voting rights held by the Company.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border: Black 1pt solid; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Name&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Place of business/ country of incorporation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Functional currency&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: Black 1pt solid; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ownership interest held by the Company&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#9;2020&amp;#9;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Principal activities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 19%; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx GmbH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 16%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Germany&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 10%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;EUR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 10%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 12%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; vertical-align: top; width: 33%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Principal operating subsidiary, biopharmaceutical company&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx Pharmaceutical Inc.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;U.S.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;USD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Subsidiary for basic research&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;2.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Basis of preparation&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated financial statements&#13;of the Group have been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting&#13;Standards Board (herein &amp;#8216;IFRS&amp;#8217;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated financial statements&#13;have been prepared on a historical cost basis. Certain prior year amounts have been reclassified for consistency with the current&#13;year presentation. &amp;#8216;Right-of-use assets&amp;#8217; have been presented separately from &amp;#8216;Property and equipment&amp;#8217; and&#13;&amp;#8216;Income tax receivable&amp;#8217; has been presented separately from &amp;#8216;Current other non-financial assets&amp;#8217; in the&#13;statements of financial position. These reclassifications had no effect on the reported results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;These consolidated financial statements&#13;of the Group comprise the Company and its wholly-owned subsidiaries InflaRx GmbH, and InflaRx Pharmaceutical Inc. The consolidated&#13;financial statements are presented in Euro (&amp;#8364;). Effective January 1, 2019, the functional currency of InflaRx N.V. has changed&#13;to the U.S. Dollar ($ or USD) from &amp;#8364;, as most of the income and expenses of InflaRx N.V. occur in $. The presentation currency&#13;of the Group did not change and continues to be &amp;#8364;, as the functional currency of the largest operating company, InflaRx GmbH,&#13;continues to be the &amp;#8364;. The functional currency of InflaRx Pharmaceutical Inc is USD. All financial information presented&#13;in Euro has been rounded to the nearest Euro, unless stated otherwise.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;2.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Summary of significant accounting policies&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;This section describes significant accounting&#13;policies adopted in the preparation of these consolidated financial statements. These policies have been consistently applied to&#13;all the years presented, unless otherwise stated.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;New and amended standards adopted by the Group&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The below listed amendments and interpretations&#13;apply for the first time in 2020, but do not have a material impact on the consolidated financial statements of the Group:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Conceptual Framework Amendments, References to the Conceptual Framework in IFRS Standards (IFRS&#13;2 Share-Based Payment, IFRS 3 Business Combinations, IAS 1 Presentation of Financial Statements, IAS 8 Accounting Policies, IAS&#13;34 Interim Financial Reporting, IAS 37 Provisions, Contingent Liabilities and Contingent Assets, IFRIC 12 Service Concession Arrangements,&#13;IFRIC 19 Extinguishing Financial Liabilities with Equity Instruments IFRIC&amp;#160;22 Foreign Currency Transactions and Advance Consideration,&#13;SIC 32 Intangible Assets &amp;#8212; Web Site Costs,), effective as of January 1, 2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 3 Business Combinations, Definition of a business, effective January 1, 2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IAS 39 Financial Instruments: Recognition and Measurement, IFRS 7 Financial Instruments Disclosures,&#13;IFRS 9 Financial Instruments, Interest Rate Benchmark Reform &amp;#8212; Phase 1, effective January 1, 2020,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IAS 1 Presentation of Financial Statements, IAS 8 Accounting Policies, Definition of Material,&#13;as of January 1, 2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;New standard not yet adopted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following amendments will be adopted&#13;effective January 1, 2021 and are not expected to have a material impact on the consolidated financial statements of the Group:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Interest Rate Benchmark Reform &amp;#8212; Phase 2, Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and&#13;IFRS 16&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;COVID-19-related Rent Concessions, Amendment to IFRS 16&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following standards issued will be&#13;adopted in a future period and the potential impact, if any, they will have on the Group&amp;#8217;s consolidated financial statements&#13;is being assessed:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IFRS 4 Insurance Contracts&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 17 Insurance Contracts, including Amendments to IFRS 17&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current&#13;or Non-current and Classification of Liabilities as Current or Non-current&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IFRS 3 Business Combinations; IAS 16 Property, Plant and Equipment; IAS 37 Provisions,&#13;Contingent Liabilities and Contingent Assets; Annual Improvements 2018-2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2: Disclosure&#13;of Accounting policies&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IAS 8 Accounting policies, Changes in Accounting Estimates and Errors: Definition&#13;of Accounting Estimates&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Current and non-current classification&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group presents assets and liabilities&#13;in the statement of financial position based on current/non-current classification.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current assets include assets that are&#13;sold, consumed or realized as part of the normal operating cycle (operating cycle is assumed to be 12 months), or cash and cash&#13;equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting&#13;period. All other assets are classified as non-current.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current liabilities, such as trade payables,&#13;lease liabilities or employee benefits with a term of up to 12 months, and payables for operating costs or social security charges,&#13;are part of the working capital used in the Company&amp;#8217;s normal operating cycle. Such operating items are classified as current&#13;liabilities even if they are due to be settled more than 12 months after the reporting period. All other liabilities are classified&#13;as non-current.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Foreign currency transactions&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Transactions in a foreign currency are&#13;initially translated into the respective functional currency using the spot rate prevailing on the dates of the transaction. Monetary&#13;items which are not denominated in the functional currency are subsequently translated using the rate applicable at the end of&#13;the period. The resulting currency gains and losses are recognized directly in profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On consolidation, the assets and liabilities&#13;of operations in a currency other than Euro (the presentation currency of the Company&amp;#8217;s) are translated into Euros at the&#13;rate of exchange prevailing at the reporting date and their statements of operations are translated with monthly average exchange&#13;rates during the reporting period. The exchange differences arising on translation for consolidation are recognized in other comprehensive&#13;income (OCI). On disposal of a foreign operation, the component of OCI relating to that particular foreign operation is reclassified&#13;to profit or loss. OCI is disclosed as &amp;#8216;other components of equity&amp;#8217; in consolidated statements of financial position.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..5.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Notes to the cash flow statement, cash, and cash equivalents&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated statements of cash flows&#13;have been prepared using the indirect method for cash flows from operating activities. The cash disclosed in the consolidated statements&#13;of cash flows is comprised of cash and cash equivalents. Cash comprises cash on hand and demand deposits. Cash equivalents are&#13;short-term bank deposits that are readily convertible to a known amount of cash and are not subject to a significant risk of changes&#13;in value with an original maturity of three month or less. Interest paid and received is included in the cash from operating activities.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..6.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Research and development expenses&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Research and development expenses comprise&#13;third party services, wages and salaries, cost of materials, intellectual property related expenses, depreciation and amortization&#13;of relevant equipment and intangibles as well as overhead. Research and development expenses mainly consist of costs for clinical&#13;trials and manufacturing of the Company&amp;#8217;s clinical drug product; additionally, costs are incurred for pre-clinical activities&#13;as well as basic research activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Development expenses must be capitalized&#13;if the criteria of IAS 38 are met. In the periods presented, no development expenses were capitalized because management does not&#13;believe all the recognition criteria of IAS 38 had been met. This assessment is due to the general uncertainties in drug development&#13;and the unpredictability of regulatory requirements. Therefore, research expenditure and development expenditures are expensed&#13;when incurred.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..7.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Employee benefits&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..7.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Liabilities for wages and salaries and&#13;cash bonuses are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as&#13;employee benefits in the consolidated statements of financial position. A liability is recognized, if the Group has a present legal&#13;or constructive obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated&#13;reliably.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..7.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Share-based payment transactions &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The grant-date fair value of equity-settled&#13;share-based payment arrangements granted to employees is generally recognized as an expense, with a corresponding increase in equity,&#13;over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which&#13;the related service conditions are expected to be met, including an estimate of forfeitures, such that the amount ultimately recognized&#13;is based on the number of awards that meet the related service conditions at the vesting date. For share-based payment awards with&#13;immediate vesting, the grant-date fair value of the share-based payment is measured to reflect such conditions and there is no&#13;gain or loss recognized for differences between expected and actual outcomes.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..8.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Lease arrangements&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group leases various properties,&#13;laboratory and office equipment and cars. Rental contracts are typically made for fixed periods of one to three years but may have&#13;renewal options. The lease agreements do not impose any covenants, but leased assets may not be used as collateral for borrowing&#13;purposes. The Group applied IFRS 16 Leases for the first time starting January 1, 2019, previous periods were not adjusted retrospectively.&#13;See Note 4.4 for the effect of this change on amounts recognized in profit or loss. Before the adoption of IFRS 16, the Group classified&#13;each of its leases (as lessee) at the inception date as either a finance lease or an operating lease. A lease was classified as&#13;a finance lease if it transferred substantially all of the risks and rewards incidental to ownership of the leased asset to the&#13;Group; otherwise it was classified as an operating lease. Before January 1, 2019, the Group did not identify any finance leases.&#13;For an operating lease, the leased property was not capitalized, and the lease payments were recognized as rent expense in profit&#13;or loss on a straight-line basis over the lease term. Any prepaid rent and accrued rent were recognized under prepayments and trade&#13;and other payables, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Set forth below are the accounting policies&#13;of the Group applied under IFRS 16 after its first-time adoption effective January 1, 2019.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..8.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Right-of-use assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group recognizes right-of-use assets&#13;at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured&#13;at cost, less any accumulated depreciation and impairment losses, and adjusted for any re-measurement of lease liabilities. The&#13;cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments&#13;made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership&#13;of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over&#13;the shorter of its estimated useful life and the lease term. On December 31, 2020, the remaining useful lives of the Company&amp;#8217;s&#13;right-of-use assets range between four and 33 months. Right-of-use assets are subject to impairment.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..8.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Lease liabilities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;At the commencement date of the lease,&#13;the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease&#13;payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments&#13;which depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include&#13;the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating&#13;a lease, if the lease term reflects the Group exercising the option to terminate. The variable lease payments that do not depend&#13;on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In calculating the present value of lease&#13;payments, the Group uses the incremental borrowing rate at the lease commencement date, since the interest rate implicit in the&#13;lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion&#13;of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is re-measured if there&#13;is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment&#13;to purchase the underlying asset.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..8.3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Short-term leases and leases of low-value assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies the short-term lease&#13;recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months&#13;or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition&#13;exemption to leases of office equipment that are considered of low value. Lease payments on short-term leases and leases of low-value&#13;assets are recognized as expense on a straight-line basis over the lease term.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..8.4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Determining the lease term of contracts &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;After the commencement date, the Group&#13;reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its&#13;ability to exercise the option to renew.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group further determines the lease&#13;term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably&#13;certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The leases which currently also result&#13;in the capitalization of a right of use asset, do not include any renewal options. For future lease contracts with potential renewal&#13;options the Company applies judgement in evaluating whether it is reasonably certain to exercise the option to renew. In doing&#13;so, management would consider all relevant factors that create an economic incentive for it to exercise the renewal.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..9.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Interest income is derived from interest-bearing&#13;financial assets, including cash equivalents. Interest income on cash and cash equivalents, financial assets at amortized cost&#13;calculated using the effective interest rate method is recognized in the consolidated statements of operations and comprehensive&#13;loss as part of finance income.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..10.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Intangible assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Intangible assets mainly comprise purchased&#13;IT software. Intangible assets are initially measured at acquisition cost, including any directly attributable costs of preparing&#13;the asset for its intended use less accumulated amortization and accumulated impairment losses, if any. Amortization begins when&#13;an asset is available for use and amortization is calculated using the straight-line method to allocate cost over the estimated&#13;useful lives. Software is amortized over three years. The useful lives of intangible assets are reviewed at each reporting date.&#13;The effect of any adjustment to useful lives is recognized prospectively as a change of accounting estimate. The Group only owns&#13;intangible assets with a definite useful life.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..11.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Laboratory and office equipment are stated&#13;at historical cost less accumulated depreciation and accumulated impairment losses, if any. Historical cost includes expenditure&#13;that is directly attributable to the acquisition of the items.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All repairs and maintenance are recognized&#13;in profit or loss during the financial period in which they are incurred, because they do not constitute a separate asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Depreciation on laboratory and office&#13;equipment is calculated using the straight-line method to allocate their cost over their estimated useful lives, as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Laboratory equipment: three to 13 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Office equipment: one to five years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The assets&amp;#8217; residual values and&#13;useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Gains and losses on disposals are determined&#13;by comparing the proceeds with the carrying amount and are recognized within &amp;#8216;other income&amp;#8217; or &amp;#8216;other expenses&amp;#8217;&#13;in the consolidated statements of operations and comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..12.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Financial assets and liabilities (financial instruments)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..12.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Definition&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A financial instrument is any contract&#13;that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity. The Group&amp;#8217;s&#13;financial assets include predominantly quoted fixed-interest debt securities. The financial liabilities comprise trade and other&#13;payables (incl. accrued liabilities from the R&amp;#38;D projects).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..12.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Criteria for the recognition and derecognition, initial measurement&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In general purchases or sales of financial&#13;assets are recognized on the settlement date, i.e., the date that the Group renders or receives the counter performance (typically&#13;cash). The Group initially measures a financial asset at its fair value plus transaction costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group initially recognizes non-derivative&#13;financial liabilities on the date that they are originated at fair value net of directly attributable transaction costs. The Group&#13;derecognizes a financial liability when its contractual obligations are discharged, cancelled, or expire.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..12.3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Subsequent measurement method&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Considering the Group&amp;#8217;s business&#13;model for managing the financial assets, whose objective is to hold them in order to collect contractual cash flows, and their&#13;contractual cash flow characteristics, that are solely payments of principal and interest on the principal amount outstanding,&#13;the Group classifies the quoted debt securities with fixed interest rates as subsequently measured at amortized cost using the&#13;effective interest method (EIR). The financial assets are also subject to impairment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s financial liabilities&#13;are classified as subsequently measured at amortized cost which is calculated by considering any discount or premium on acquisition&#13;and fees or costs that are an integral part of the EIR.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;An analysis of the carrying amounts from&#13;the consolidated statements of financial position by measurement category is disclosed under &amp;#8216;under &amp;#8216;4.7 Financial&#13;assets and financial liabilities.&amp;#8217;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..12.4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Criteria for realization of income and expenses&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Interest income is accrued using the&#13;relevant effective interest rate. Interest expense on liabilities, if any, is also accrued based on the effective interest rate.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Gains and losses on the disposal of financial&#13;instruments are recognized in full when all significant risks and rewards have been transferred. In the case of a partial transfer&#13;of risks and rewards, a distinction would be made as to whether control remains with the company or is transferred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Impairment losses on financial assets&#13;are recognized in profit or loss. The Group recognizes an allowance for expected credit losses (ECLs) for the financial assets&#13;held, see Note &amp;#8216;3.4 Net Financial Result&amp;#8217;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;ECLs are based on the difference between&#13;the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted&#13;at an approximation of the original effective interest rate. ECLs are generally recognized in two stages. For credit exposures&#13;for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses&#13;that result from default events that are possible within the next 12-months (a 12-month ECL). For those credit exposures for which&#13;there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses&#13;expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL). For the quoted debt&#13;securities with fixed interest rates, which have high credit ratings and no significant increases in credit risk since initial&#13;recognition, the Group determines the exposure to credit default using CDS pricing information (i.e. credit default swap values)&#13;published by credit agencies and recognizes a 12-month ECL.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..13.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Fair Value Measurement&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group does not measure any financial&#13;asset or liability at fair value. The carrying amount of all financial instruments approximates their fair value, with the exception&#13;of quoted debt securities which fair values are disclosed (see &amp;#8216;4.7 Financial assets and financial liabilities&amp;#8217;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;When measuring the fair value of an asset&#13;or a liability, the Group would use observable market data as far as possible. Fair values are categorized into different levels&#13;in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 1, quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 2, inputs other than quoted prices included within Level 1 that are observable for the instrument,&#13;either directly (as prices) or indirectly (derived from prices).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 3, inputs for instruments that are not based on observable market data (unobservable inputs).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;If the inputs used to measure the fair&#13;value of an asset or a liability fall into different levels of the fair value hierarchy, then the fair value measurement is categorized&#13;in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group would recognize transfers between&#13;levels of the fair value hierarchy at the end of the reporting period during which the change has occurred.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..14.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Income tax&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Income taxes comprise current and deferred&#13;taxes. Current and deferred taxes are recognized in profit or loss except to the extent that they relate to items recognized directly&#13;in equity or in other comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..15.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Current income tax&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current income tax assets and liabilities&#13;are measured at the amount expected to be recovered from or paid to the taxation authorities. Expected tax payable or receivable&#13;on the taxable income or loss for the year, are calculated using tax rates enacted or substantively enacted at the reporting date,&#13;and any adjustment to tax payable in respect of previous years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the periods presented; the Group did&#13;not incur income tax expense. Taxes withheld by banks and remitted to tax authorities were reimbursed after filing of the annual&#13;tax declaration.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;2.2..16.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Deferred income tax&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is recognized in respect&#13;of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts&#13;used for taxation purposes. Deferred tax is not recognized for temporary differences associated with assets and liabilities if&#13;the transaction which led to their initial recognition is a transaction that is not a business combination and that affects neither&#13;accounting nor tax profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is measured at the tax rates&#13;that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively&#13;enacted by the reporting date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax assets arising from tax&#13;loss carryforwards are recognized only to the extent that the Group has sufficient taxable temporary differences or there is convincing&#13;evidence that sufficient future taxable profit will be available against which the unused tax losses can be utilized. As of December&#13;31, 2020 and 2019, based on management&amp;#8217;s judgment, it was not probable that taxable profit will be available against which&#13;the unused tax losses can be utilized; no deferred tax assets were therefore recognized in the consolidated statements of financial&#13;position.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;2.3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Significant accounting judgements, estimates and assumptions&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The preparation of the consolidated financial&#13;statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application&#13;of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these&#13;estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Estimates and underlying assumptions&#13;are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised&#13;and in any future periods affected. In preparing these consolidated financial statements, the critical judgments made by management&#13;in applying the Group's accounting policies involve the following areas:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;i&gt;Accounting for share-based payments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;When determining the grant date fair&#13;value of share-based payment awards, assumptions must be made regarding the key parameters of the grant (see Note &amp;#8216;3.6.2&#13;Measurement of fair values of share options granted&amp;#8217;). In 2020, the Company kept its share price volatility assumption at&#13;135% which has been used for the valuation of all share option grants since June 2019. Although the average volatility has decreased&#13;to approximately 130% since June 2019, management believes that an average volatility of 135% is still appropriate as future value&#13;inflection points will influence the share price of the Company and consequently will increase the volatility. Additionally, the&#13;Company must estimate the number of equity instruments which will vest in future periods as awards may be forfeited prior to vesting&#13;due to an awardee&amp;#8217;s failure to satisfy a performance condition, including due to employment termination. An assumption of&#13;the forfeiture rate must be made based on historical information and adjusted to reflect future expectations. Revisions to the&#13;forfeiture rate could result in a cumulative effect of the change in estimate for current and prior periods to be recognized in&#13;the period of change (see Note 3.6.3 &amp;#8216;Change in the accounting estimate of the share options expected to vest&amp;#8217;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;i&gt;Measurement of third-party R&amp;#38;D&#13;clinical trial accruals and related expense &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In measuring R&amp;#38;D expenses for the&#13;reporting period, the Company estimates the amount of expense to recognize and liability to accrue as far as the invoices of third-party&#13;service providers are not yet received (e.g. for pass-through costs charged by the Company&amp;#8217;s contract research organizations&#13;(&amp;#8216;CROs&amp;#8217;) and exceed any prepayments made. The timing of the invoicing of project services by CROs follow contractual&#13;billing schedules and can occur several months prior to or following a reporting period. This estimation involves determining a&#13;percentage-of-completion whereby the degree to which services have been rendered for the individual project activities contracted&#13;from the CRO is assessed and estimated by in-house R&amp;#38;D project managers and reviewed by the controlling department. This percentage-of-completion&#13;is used to measure the amount of the unbilled project activities which have already been rendered by the reporting date and the&#13;associated R&amp;#38;D expense and liability to recognize as a result.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The percentage-of-completion estimates&#13;are based on the best information available at the time. However, additional information may become available in the future and&#13;management may adjust the estimate in such future periods. In this event, the Company may be required to record adjustments to&#13;research and development expenses in future periods when the actual level of activity becomes more certain. The Company considers&#13;resulting increases or decreases in expenses as changes in estimates and reflects such changes in research and development expenses&#13;in the period identified.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company has accrued &amp;#8364;5,250,654&#13;as of December 31, 2020 and &amp;#8364;8,274,042 as of December 31, 2019 (see Note 4.10 Trade and other payables) in third-party clinical&#13;trial accruals. As of these dates, prepayments were recorded for those payments made against which no services had yet been rendered&#13;(2020: &amp;#8364;1,923,365, 2019: &amp;#8364;698,891, see Note 4.5 Other non-financial assets).&lt;/p&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <IFRX:DisclosureOfConsolidatedStatementsOfOperationsAndComprehensiveLossExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 21.6pt"&gt;&lt;font style="font-size: 8pt"&gt;3.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Research and development expenses&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Research and development decreased in&#13;2020 compared to in 2019 due to the Company&amp;#8217;s lower activities in the area of clinical studies and manufacturing. The items&#13;below comprise research and development expenses.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Research and development expenses&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Third-party services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;19,886,693&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;36,783,223&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,909,366&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;manufacturing of clinical material&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;3,075,347&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;13,479,235&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;4,828,534&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;clinical, pre-clinical&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;16,811,346&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;23,303,988&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;11,080,832&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Employee benefits expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,480,890&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,231,812&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,037,082&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Equity-settled share-based payment expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;626,833&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;2,580,983&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;5,256,194&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;862,364&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;668,676&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;421,041&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;454,193&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;898,425&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;661,065&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;25,684,140&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;44,582,136&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;25,028,554&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;3.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;General and administrative expenses include&#13;the items below. Compared to the prior year the decrease is mainly caused by lower employee benefits expenses, as well as a decrease&#13;of the Company&amp;#8217;s business activities and the expense of operating as a public company in the United States.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;General and administrative expenses&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Employee benefits expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,880,349&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,534,073&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,146,955&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Equity-settled share-based payment expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;489,958&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;4,251,227&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;6,828,457&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,603,711&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,199,640&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,020,447&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Insurance expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,311,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,035&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;368,339&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation &amp;#38; amortization expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;556,456&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;503,683&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;115,330&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Compensation expense for non-executive board directors&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;283,128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;269,030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;238,180&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;831,769&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,358,587&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;897,618&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,467,203&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,501,048&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,786,869&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;3.3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Employee benefits expenses&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following table shows the items of&#13;employee benefits expenses:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Employee benefits expenses&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Wages and salaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,270,757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,974,807&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,501,840&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Social Security contributions (employer's share)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;551,804&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;562,255&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;350,024&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Equity-settled share-based payment expenses (see Note 3.6 Share-based payments)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,116,791&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,832,210&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,084,651&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;421,887&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;396,613&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;247,522&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,361,239&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;13,765,885&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;17,184,037&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The number of employees rose to 47.3&#13;full time equivalents (FTEs) at the end of 2020 from 43.7 FTEs at the end of 2019 and 36.8 FTEs at the end of 2018 (numbers are&#13;as of December 31 and are not annual average numbers).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;3.4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net Financial Result&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;3.4..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Finance Result&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Finance Result&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;887,702&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,840,676&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,842&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Finance expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(18,689)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(9,500)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest on lease liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(7,311)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(12,765)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;861,702&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,818,411&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,182,842&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;3.4..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange result&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 55%; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Foreign exchange result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Foreign exchange result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,656,922&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,379,644&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,249,853&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(4,433,435)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(2,684,700)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(2,623,782)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(776,513)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;694,944&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;5,626,071&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Foreign exchange income and expense&#13;is mainly derived from group entities that do not use the U.S. dollar as their functional currency. Those entities translate U.S.&#13;dollar cash, cash equivalents and marketable securities at the exchange rates prevailing on the reporting date. Any resulting&#13;translation di&amp;#64256;erences are recognized in pro&amp;#64257;t and loss. These gains and losses are caused by a change in the exchange&#13;rates as of the reporting dates and may not ultimately be realized.&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;3.4..3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Other financial result&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Other financial result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(126,000)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(107,182)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Other financial result is comprised of&#13;an expense of &amp;#8364;126,000 (nil in 2019 and 2018) due to an adjustment to the expected credit loss allowance in 2020, which is&#13;deducted from the Company&amp;#8217;s current and non-current financial assets (please also refer to 4.5 &amp;#8216;Other non-financial&#13;assets&amp;#8217;).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;3.5.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Loss per share&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Loss per common share is calculated by&#13;dividing the loss of the period by the weighted average number of common shares outstanding during the period. The weighted number&#13;of common shares outstanding for the financial year 2020 is 27,064,902, for 2019 is 26,004,519 and for 2018 is 25,095,027.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;For the period in which the Company is&#13;in a loss-making situation, the diluted loss per share is the same as basic loss per share, because the weighted average number&#13;of shares to be issued upon the exercise of the stock options would produce an anti-dilutive effect.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;3.6.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;3.6..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Equity-settled share-based payment arrangements&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the course of its historical financing&#13;rounds prior to 2016, InflaRx GmbH established equity-settled share-based payment programs. Those InflaRx GmbH options were converted&#13;into options for common shares of InflaRx N.V. in November 2017:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 41%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;148,433&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;289,309&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercised during the year (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(140,876)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;148,433&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;148,433&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at December 31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;148,433&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;148,433&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 1.85pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;* Weighted average share price (WAEP) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The weighted average remaining contractual&#13;life for the share options outstanding as at 31 December 2020 was 2.43 years (2019: 3,43 years). The exercise price for all options&#13;outstanding at the end of the year was &amp;#8364;0.01 per share or less (2019: &amp;#8364;0.01 or less).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Under the terms and conditions of the&#13;share option plan of 2016 (the &amp;#8220;2016 Plan&amp;#8221;), InflaRx GmbH granted rights to subscribe for InflaRx GmbH&amp;#8217;s common&#13;shares to directors, senior management, and key employees. Those InflaRx GmbH options were converted into options for common shares&#13;of InflaRx N.V. in November 2017:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 40%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;1,181,484&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;1,181,484&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;7,81&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercised during the year (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(86,632)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.94&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,094,852&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,181,484&#13;        &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.98&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at December 31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,094,852&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,181,484 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.98&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 16.05pt; text-indent: -14.2pt"&gt;&lt;font style="font-size: 8pt"&gt;* conversion rates used for one &amp;#8364;: December 31, 2020 $0.8149, average rate 2020 $0.8762, January 1, 2020/December 31, 2019 $0.8902, average rate 2019 $0.8932&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The weighted average remaining contractual&#13;life for the share options outstanding as at December 31, 2020 was 10.93 years (2019: 11.95 years).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In conjunction with the closing of its&#13;initial public offering, InflaRx N.V. established a new incentive plan (the &amp;#8220;2017 Long-Term Incentive Plan&amp;#8221;). The initial&#13;maximum number of common shares available for issuance under equity incentive awards granted pursuant to the 2017 Long-Term Incentive&#13;Plan equals 2,341,097 common shares:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 40%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2,181,105&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.44 /&amp;#8364;3.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2,051,009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.61/&amp;#8364;3.16 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Granted during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;246,188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$4.83 /&amp;#8364;4.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;242,450 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.25/&amp;#8364;2.91 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercised during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(78,342)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.35 /&amp;#8364;2.94&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Forfeited during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(202,473)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.61 /&amp;#8364;3.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(112.354)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$6.17/&amp;#8364;5.51 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,146,478&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.59 /&amp;#8364;2.93&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,181,105&#13;        &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.44/&amp;#8364;3.06 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at December 31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,863,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.46 /&amp;#8364;2.82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,319,548 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.52/&amp;#8364;3.13 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 8.95pt; text-indent: -7.1pt"&gt;&lt;font style="font-size: 8pt"&gt;* conversion rates used for one &amp;#8364;: December 31, 2020 $0.8149, average rate 2020 $0.8762, January 1, 2020/December 31, 2019 $0.8902, average rate 2019 $0.8932&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The weighted average remaining contractual&#13;life for the share options outstanding as at December 31, 2020 was 5.38 years (2019: 6.21 years). For grants with unvested share&#13;options outstanding at December 31, 2020, the options granted vest over a period of two or three years, depending on the grant,&#13;with &lt;font style="letter-spacing: 0.2pt"&gt;1/2 or 1/3, respectively, of the options vesting after the end of the 1st year after vesting&#13;start and the remaining options vesting monthly &lt;/font&gt;in equal portions thereafter. Vesting of these unvested share options is&#13;subject to the service condition of remaining employed at the time of vesting and no market or performance conditions are applicable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The weighted average fair value of options&#13;granted during the year was $3.88/&amp;#8364;3.40 (2019: $8.16/&amp;#8364;7.29). The range of exercise prices for options outstanding at&#13;the end of the year was $2.28/&amp;#8364;1.86 to $22.75/&amp;#8364;18.54 (2019: 2.28/&amp;#8364;2.03 to $22.75/&amp;#8364;20.25).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On July 3, 2019, the Board of Directors&#13;approved an amendment of the 2016 Share Option Plan and the 2017 Long-Term Incentive Plan. Following the amendment, the exercise&#13;price of all vested and unvested options, other than those held by persons who were not employees or directors at the time of the&#13;amendment, was reduced to $3.35 per share. The repricing decision on July 3, 2019 affected 1,181,484 share options from the 2016&#13;Plan and 2,105,459 share options from the 2017 Long-Term Incentive Plan. The valuation of past grants with the new exercise price&#13;of $3.35 resulted in an increase in fair value of the outstanding options (i.e. additional compensation expense was recognized).&#13;Please refer to the table below regarding the measurement of fair values of share options granted.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;There were no cancellations or further&#13;modifications to the awards in 2020, 2019 or 2018.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;3.6..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Measurement of fair values of share options granted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The fair value of options granted in&#13;2020 under the 2017 Long-Term Incentive Plan was determined using the Black-Scholes valuation model. As the Company&amp;#8217;s common&#13;shares are listed on the Nasdaq Global Select Market, the closing price of the common shares at grant date was used.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The modification, resulting from the&#13;repricing as described above, increased the fair value of the equity instruments granted under the 2017 Long-Term Incentive Plan&#13;and the 2016 Plan. In accordance with IFRS 2.B43, the incremental fair value is recognized over the remaining vesting period, whereas&#13;the balance of the grant-date fair value is recognized immediately for fully vested options, or over the remaining original vesting&#13;period. The incremental fair value is the difference between the fair value of the modified share-based payment and that of the&#13;original share-based payment, both measured at the date of the modification - i.e. July 3, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Other significant inputs into the model&#13;are as follows (weighted average):&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 19%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Share options granted&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair value per &lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;option&lt;/b&gt;&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;FX rate&#13;        as of grant date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair value per &lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;option&lt;/b&gt;&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Share price at grant date / &lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Exercise price&lt;/b&gt;&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Expected&#13;        volatility&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Expected life&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;(midpoint based)&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Risk-free rate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;(interpolated, U.S. sovereign strips curve)&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;January 1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$14.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;12.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$26.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;3,00%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;February 4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;18,450&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$18.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;15.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$32.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2,60%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;May, 14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;36,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$22.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.89&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;20.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$41.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2.30%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Repricing, July 3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$0.46-$1.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.89&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.40-&amp;#8364;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2.3-4.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2.30%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;October 24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$1.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;1.76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$2.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1,65%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;December 16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;38,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;2.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1,79%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;December 16*&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;2.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1,79%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-top: Black 0.5pt solid; border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"&gt;&lt;b&gt;242,450&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td colspan="9" style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;On November 20, 2018, 75,000 stock options were awarded subject to a specified condition, which was satisfied on January 1, 2019, therefore, the expense for these share options was recognized in 2019.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td colspan="9" style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;* Options granted to the executive management&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;September 18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;71,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;3.52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.36%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;September 18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;25,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;3.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;5.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.39%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;October 1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;3.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.28/$4.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;5.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.36%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-top: Black 0.5pt solid; border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"&gt;&lt;b&gt;246,188&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="9" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 1.5pt; text-indent: 0in"&gt;Of the options granted in 2020, 200,000&#13;        were granted to members of the executive management. For 150,000 options out of those, the grant date, as it is defined by IFRS&#13;        2, is determined to be October 1, 2020, the start of the awardee&amp;#8217;s employment.&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 1.5pt; text-indent: 0in"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="9" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 1.5pt; text-indent: 0in"&gt;Expected dividends are nil for all share&#13;        options listed above.&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 1.5pt; text-indent: 0in"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Expected volatility has been based on&#13;the historical volatility of the Company&amp;#8217;s share price. Considering a significant price drop on June 5, 2019, averages were&#13;calculated including and excluding this trading day which results in an average volatility of 128% (124% in 2019). For grants after&#13;June 2019 the Company has selected a volatility of 135% which accounts for expectations of the management.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The range of outcomes for the expected&#13;life of the instruments has been based on expectations on option holder behavior in the scenarios considered.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The dividend yield has no impact due&#13;to the anti-dilution clause as defined in the 2017 Long-Term Incentive Plan.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The annual general meeting on July 16,&#13;2020, approved an amendment to the 2017 Long-Term Incentive Plan (LTIP) with effect from January 1, 2021:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;increasing the maximum annual number of common shares in the Company&amp;#8217;s capital available&#13;for issuance under the LTIP, starting on January 1, 2021, to 4% (from 3%) of the Company&amp;#8217;s outstanding common shares (determined&#13;as of December 31 of the immediately preceding year); and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;removing certain restrictions from the LTIP, which will allow the committee administering the&#13;LTIP and the Board to (i) lower the exercise price per share of any options and/or share appreciation rights issued under the LTIP&#13;or take any other action treated as a &amp;#8216;repricing&amp;#8217; of an award and (ii) cancel any option and/or share appreciation&#13;rights in exchange for cash or another award granted under the LTIP, in either case, without prior approval of the Company&amp;#8217;s&#13;shareholders.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;3.6..3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in the accounting estimate of the share options expected to vest&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Due to terminations in the third quarter&#13;of 2020, effective July 1, 2020, the Company has revised its forfeiture assumptions regarding the number of equity instruments&#13;that will vest in future quarters. As a result of this change in estimate, the Company recognized a benefit of &amp;#8364;64.0 thousand&#13;in research and development expenses and a benefit of &amp;#8364;72.9 thousand in general and administrative expenses in 2020 and will&#13;recognize &amp;#8364;41.5 thousand less expense in research and development expenses and &amp;#8364;27.0 thousand less expense in general&#13;and administrative expenses from share-based payments in the remaining vesting periods until June 30, 2022. The forfeiture assumptions&#13;will be continuously monitored and adjusted when necessary and appropriate.&lt;/p&gt;</IFRX:DisclosureOfConsolidatedStatementsOfOperationsAndComprehensiveLossExplanatory>
    <IFRX:DisclosureOfConsolidatedStatementsOfFinancialPositionExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 45%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Property&#13;        and equipment&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Advance&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;payments&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(in &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;995,179&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;995,179&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;259,647&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;54,338&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;313,985&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(142,400)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(142,400)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Reclassification&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;54,408&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(54,408)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,639&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;70&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,709&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,173,473&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,173,473&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;66,114&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;66,114&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(5,298)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(5,298)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(34,750)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(34,750)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,199,540&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,199,540&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Accumulated depreciation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(370,510)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(370,510)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(252,627)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(252,627)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;26,235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;26,235&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(198)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(198)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(597,101)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(597,101)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(212,733)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(212,733)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,793&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,793&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;16,764&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;16,764&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(791,277)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(791,277)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Net book value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;576,372&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;576,372&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;408,263&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;408,263&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Right-of-use assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; width: 45%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Cars&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(in &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;695,614&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;35,058&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;730,672&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,754&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,754&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(266,057)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(266,057)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,512&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,512&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,067,823&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;35,058&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,102,881&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,993&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,993&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(28,366)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(28,366)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(7,997)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(7,997)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,059,826&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;108,685&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,168,512&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Accumulated depreciation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(283,350)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(20,831)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(304,181)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;38,008&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;38,008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;216&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(245,126)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(20,831)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(265,957)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(335,608)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(34,410)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(370,018)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,880&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,277&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,277&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(574,457)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(47,361)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(621,818)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Net book value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;822,697&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;14,227&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;836,924&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;485,369&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;61,324&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;546,694&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Intangible Assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 45%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Purchased&#13;        IT-software&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Advances&#13;        paid for software&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(in &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;246,351&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;109,852&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;356,204&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;84,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;251,493&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;335,942&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Reclassification&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;353,155&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(353,155)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(64)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(64)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;683,891&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,190&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;692,081&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28,075&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Reclassification&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(8,190)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(562)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(562)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;719,593&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;719,593&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Accumulated amortization&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(133,337)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(133,337)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Amortization charge for the year*&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(106,358)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(106,358)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;14&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(239,681)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(239,681)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Amortization charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(129,963)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(129,963)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;234&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(369,410)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(369,410)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Net book value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;444,210&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,190&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;452,400&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;350,184&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;350,183&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Amortization of intangible assets is&#13;included in the line items &amp;#8216;research and development expenses&amp;#8217; (2020: &amp;#8364;27,937, 2019: &amp;#8364;30,662, 2018: &amp;#8364;5,841)&#13;and &amp;#8216;general and administrative expenses&amp;#8217; (2020: &amp;#8364;102,026, 2019: &amp;#8364;75,696, 2018: &amp;#8364;19,414) in the consolidated&#13;statements of operations and comprehensive loss.&lt;br style="clear: both" /&gt;&#13;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Leases&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Lease obligations consist of payments&#13;pursuant to non-cancellable lease agreements mainly relating to the Company&amp;#8217;s leases of office space. The lease terms of&#13;the Company&amp;#8217;s premises expire in the next 24 months: Jena, Germany in December 2022, Martinsried, Germany in May 2022 and&#13;Ann Arbor, United States in April 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Set out below, are the carrying amounts&#13;and the movements of the Group&amp;#8217;s lease liabilities:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Lease liabilities&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As of January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;845,948&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;730,672&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,993&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,754&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Derecognition&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(20,555)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(228,547)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 8.65pt; padding-left: 8.65pt; text-indent: -8.65pt"&gt;&lt;font style="font-size: 8pt"&gt;Re-payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(366,156)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(296,020)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term liability for accrued interest expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(388)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,362&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange difference&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(1,802)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,727&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As of December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;559,041&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;845,948&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 72%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following are the amounts recognized&#13;in profit or loss:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 61%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020*&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019*&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018*&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: right; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation expense of right-of-use assets (see Note 4.2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;362,137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;265,957&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest expense on lease liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,311&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,765&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Rental expense from leases&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,275&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;70,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;213,200&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 17.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;short-term leases (included in administrative expenses)&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;937&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;65,348&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 17.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;leases of low-value assets (included in administrative expenses)&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;i&gt;5,338&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;i&gt;5,103&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total amounts recognized in profit or loss&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;375,723&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;349,173&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;213,200&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 15.7pt; background-color: white"&gt;* in 2020 and 2019&#13;leases under IFRS 16, in 2018 operating leases under IAS 17&lt;br /&gt;&#13;&lt;br /&gt;&#13;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group had total cash outflows for&#13;leases of &amp;#8364;374,698 in 2020 (&amp;#8364;378,035 in 2019, &lt;font style="background-color: white"&gt;&amp;#8364;213,200 in 2018&lt;/font&gt;).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.5.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 70%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Other assets&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Non-current other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepaid expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;353,522&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;452,217&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;353,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;452,217&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Current other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepayments on research &amp;#38; development projects&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,340,643&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;698,891&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepaid expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,295,682&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,467,936&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;98,374&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;199,088&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;3,734,699&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,365,915&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;4,088,221&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,818,132&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Prepayments on research &amp;#38; development&#13;projects consists of prepayments on CRO and manufacturing contracts. Prepaid expense mainly consists of prepaid insurance expense.&lt;br style="clear: both" /&gt;&#13;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.6.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Income tax&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;4.6..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Income tax reconciliation&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The table below shows a reconciliation&#13;between the product of loss before tax multiplied by the Company's applicable tax rate and current income taxes recognized in profit&#13;or loss.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;InflaRx Group&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Loss for the period (accounting profit before income tax)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(33,983,614)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(53,254,817)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(29,814,634)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;29.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;29.1%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Tax benefits at tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,761,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,815,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,715,116&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Tax losses for which no deferred tax asset was recognized&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(9,761,910)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(15,815,083)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(8,715,116)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Income tax&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The tax rate applied above represents&#13;the weighted average of the statutory tax rates in Germany and the USA. In Germany, InflaRx N.V. and its German subsidiary InflaRx&#13;GmbH are subject to corporate income tax (2020/2019/2018: 15%), a solidarity surcharge (2020/2019/2018: 0.8%) and trade taxes (2020:&#13;13.0%, 2019: 13.9%, 2018: 13.4%). This equals an average total tax rate of 28.9% in 2020 (2019: 29.7%, 2018: 29.2%). InflaRx Pharmaceutical&#13;Inc., Ann Arbor, Michigan, USA is subject an average total tax rate of 27.0% in 2020 (2019 and 2018: 27.0%), which is made up of&#13;U.S. federal tax (2020, 2019, 2018: 21%) and state tax (2020, 2019, 2018: 6%).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;4.6..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Tax losses carried forward &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has total tax loss carryforwards&#13;of &amp;#8364;148.9 million (2019: &amp;#8364;114.4 million) from three areas that cannot be utilized outside these areas:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;As of December 31, 2020 the Group has &amp;#8364;107,188,000 (2019: &amp;#8364;75,767,524) of unrecognized&#13;and unused tax losses carried forward attributable to the tax group formed by InflaRx N.V. since 2018; these tax losses do not&#13;expire and may not be used to offset taxable income elsewhere in the Group. Since January 1, 2018, InflaRx GmbH has distributed&#13;its losses to the parent Company InflaRx N.V. under a profit and loss transfer agreement. This tax group was formed in Germany&#13;and is subject to German tax legislation. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Tax losses of InflaRx GmbH until December 31, 2017 (&amp;#8364;34,787,000) are frozen from 2018 onwards&#13;due to the tax group with InflaRx N.V. Those losses of InflaRx GmbH do not expire and may be used to offset future taxable income&#13;of InflaRx GmbH only. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;In addition, the Group still has tax loss carryforwards of &amp;#8364;6,971,000 (2019: 3,816,023)&#13;from the operations of InflaRx Pharmaceutical Inc. which can also only be utilized there, generally do not expire, but are generally&#13;limited to 80% of taxable income.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As of December 31, 2020 and 2019, no&#13;deferred tax assets were recognized for the carryforward of unused tax losses.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;4.6..3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Current income tax receivable&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current income tax receivable includes&#13;tax claims because of income tax withheld on interest income earned by the Group on the financial assets (2020: &amp;#8364;1,026,494,&#13;2019: &amp;#8364;1,134,968). The Company is reimbursed for the payments after filing a tax return.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.7.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Financial assets and financial liabilities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Set out below is an overview of financial&#13;assets and liabilities, other than cash and short-term deposits included in cash equivalents, held by the Group as at December&#13;31, 2020 and December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 70%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Financial assets and financial liabilities&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Non-current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;272,268&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;272,614&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;47,138,738&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;82,353,867&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Trade and other payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,258,133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,413,662&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The fair value of current and non-current&#13;financial assets amounted to &amp;#8364;47,392 thousand (level 1; 2019: &amp;#8364;82,661 thousand). The Group&amp;#8217;s financial assets&#13;at amortized cost consist mainly of quoted debt securities with fixed interest rates that are graded in the top investment category&#13;(AAA) by credit rating agencies such as S&amp;#38;P Global and, therefore, are considered low credit risk investments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The maturities of all securities as of&#13;December 31, 2020 are between three and eleven months (2019: between one and eleven months); they bear nominal fixed interest in&#13;the range of 1.4% to 3.1% (2019: 1.5% to 2.1%).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.8.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Cash and cash equivalents &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 70%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Cash and cash equivalents&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Short-term deposits&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Deposits held in U.S. dollars (3 months original maturity and less)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;22,616,767&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;27,803,153&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Deposits held in Euro (3 months original maturity and less)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,800,000&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;24,416,767&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;27,803,153&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cash at banks&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash held in Euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,189,126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,211,478&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash held in U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;362,788&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;4,116,649&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,551,914&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;5,328,127&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;25,968,681&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;33,131,280&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.9.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Equity&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;4.9..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Issued capital&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As of December 31, 2020, the issued capital&#13;of the Company is divided into 28,228,415 common shares (2019: 26,105,255). The nominal value per share is &amp;#8364;0.12. All shares&#13;issued are fully paid and have the same rights on the distribution of dividends and the repayment of capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On July 8, 2020, the Company filed with&#13;the United States Securities and Exchange Commission (SEC) a Form F-3 with respect to the offer and sale of securities of the Company.&#13;The Company also filed with the SEC a prospectus supplement relating to an at-the-market program providing for the sales over time&#13;of up to $50 million of its common shares pursuant a Sales Agreement with SVB Leerink LLC. As of December 31, 2020, the Company&#13;had issued 1,958,186 common shares under this program resulting in &amp;#8364;9.0 million in net proceeds to the Company. Following&#13;these issuances, the remaining value authorized for sale under the at-the-market program is $38.8 million. Refer to Note 7.4 regarding&#13;additional equity issuances subsequent to December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;4.9..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Authorized capital&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;According to the articles of association&#13;of the Company, up to 55,000,000 common shares and up to 55,000,000 preferred shares with a nominal value of &amp;#8364;0.12 per share&#13;are authorized to be issued. All shares are registered shares. No share certificates shall be issued.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In order to deter acquisition bids, the&#13;Company&amp;#8217;s general meeting of shareholders approved the right of an independent foundation under Dutch law, or protective&#13;foundation, to exercise a call option pursuant to the call option agreement, upon which preferred shares will be issued by the&#13;Company to the protective foundation of up to 100% of the Company&amp;#8217;s issued capital held by others than the protective foundation,&#13;minus one share. The protective foundation is expected to enter into a finance arrangement with a bank or, subject to applicable&#13;restrictions under Dutch law, the protective foundation may request us to provide, or cause the Company&amp;#8217;s subsidiaries to&#13;provide, sufficient funding to the protective foundation to enable it to satisfy its payment obligation under the call option agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;These preferred shares will have both&#13;a liquidation and dividend preference over the Company&amp;#8217;s common shares and will accrue cash dividends at a pre-determined&#13;rate. The protective foundation would be expected to re-quire us to cancel its preferred shares once the perceived threat to the&#13;Company and its stakeholders has been removed or sufficiently mitigated or neutralized. The Company is of the opinion that the&#13;call option does not represent a significant fair value based on a level 3 valuation, since the preference shares are restricted&#13;in use and can be cancelled by us as stated above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;For the year ended December 31, 2020,&#13;the Company expensed &amp;#8364;60,000 of ongoing costs to reimburse expenses incurred by the protective foundation.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;4.9..3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Nature and purpose of equity reserves&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In addition to the issued capital, the&#13;Company discloses the following other reserves:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Share premium&lt;/i&gt; records the amounts paid in upon issuance of common shares in excess of nominal&#13;value of &amp;#8364;0.12 per share, net of related transaction costs.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;The &lt;i&gt;other capital reserves&lt;/i&gt; include the expense resulting from the issue of share options.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Accumulated deficit&lt;/i&gt; includes the losses of previous reporting periods.&amp;#9;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Other components of equity&lt;/i&gt; exclusively include currency reserves from the conversion of&#13;financial statements in foreign currencies&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;4.10.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Trade and other payables&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 70%; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Trade and other Payables&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Accrued liabilities from R&amp;#38;D projects&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,250,654&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,274,042&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,741,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,351,100&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other accrued liabilities and payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,266,228&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;788,520&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total trade and other payables&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,258,133&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,413,662&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Accrued liabilities from R&amp;#38;D projects include the services from&#13;the Company&amp;#8217;s ongoing projects that have not yet been invoiced to the Company as of the reporting date.&lt;/p&gt;</IFRX:DisclosureOfConsolidatedStatementsOfFinancialPositionExplanatory>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;5.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Financial risk management&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;5.1..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Financial risk management objectives and policies&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s risk management is&#13;predominantly controlled by central treasury activities under an investment policy approved by the Board of Directors. Those treasury&#13;activities identify, evaluate and manage financial risks consistent with the Group&amp;#8217;s operating needs. The board provides&#13;policies for overall risk management, covering specific areas, such as foreign exchange risk and credit risk. The Company does&#13;not intend to use derivative financial instruments because the Group&amp;#8217;s future risk exposures cannot be reliably forecasted&#13;(volume of business activity, liquidity needs, foreign exchange exposure).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Hedging is not applied as most of the&#13;business activity is intended to be executed in U.S. Dollars and paid with the U.S. Dollars funds raised in public offerings. The&#13;foreign exchange exposure from costs incurred in currencies other than Euro is deemed immaterial.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s principal financial&#13;assets comprise quoted debt securities with credit ratings of AAA. Besides these financial assets, the Group has significant cash&#13;and cash equivalents. The Group&amp;#8217;s principal financial liabilities comprise trade and other payables. The main purpose of&#13;these financial assets, cash/cash equivalents and liabilities are to finance the Group&amp;#8217;s development activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group is exposed to market risk,&#13;credit risk and liquidity risk. The Board of Directors reviews and adopts policies for managing each of these risks, which are&#13;summarized below. The Group&amp;#8217;s senior management oversees the management of these risks.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="border: Black 1pt solid; width: 13%; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; width: 35%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; width: 20%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Measurement&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; width: 32%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Risk Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Market risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Future development costs; Recognized financial assets and liabilities not denominated in Euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Forecasted cash flows Sensitivity analysis&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Achievement of a natural hedge&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;in the future&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Cash and cash equivalents,&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;current and non-current financial assets&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Credit&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;rating&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Diversification of bank deposits, Investment&#13;        guidelines for&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;debt investments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Liquidity&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;R&amp;#38;D and G&amp;#38;A cost, equity, trade and other payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Rolling&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;cash flow forecast&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Availability of funds through financing rounds or public offerings&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;5.1..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Market risk&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Market risk is the risk that changes&#13;in market prices (e.g. due to foreign exchange rates) will affect the Group&amp;#8217;s income, expenses or the value of its holdings&#13;of financial instruments. The objective of market risk management is to identify, manage and control market risk exposures within&#13;acceptable parameters.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Foreign exchange risk arises when commercial&#13;transactions or recognized assets or liabilities are denominated in a currency that is not an entity&amp;#8217;s functional currency.&#13;The Group is exposed to transactional foreign currency risk to the extent that there is a mismatch between the currencies in which&#13;costs and purchases are denominated and the respective functional currencies of Group companies. The functional currencies of Group&#13;companies are primarily the U.S. dollars and Euro. The currencies in which these transactions and financial assets are primarily&#13;denominated are U.S. dollars and Euro. The Group is exposed to the exchange rate between the Euro and the U.S. dollars. Due to&#13;the initial public offering in 2017, follow-on public offering in 2018 and at-the-market program share issuances in 2020, the Group&#13;has a significant cash and cash equivalents in U.S. dollars. Currently the Group does not hedge U.S. dollars but intends to achieve&#13;a natural hedge by contracting suppliers in U.S. dollars in the future. In 2020, the Group recognized significant foreign exchange&#13;gains and losses as the natural hedge is not yet achieved and the functional currency for InflaRx GmbH is Euro.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group is primarily exposed to changes&#13;in U.S. dollar to Euro exchange rates. The sensitivity of profit or loss to changes in the exchange rates arises mainly from U.S.&#13;dollar denominated financial instruments at InflaRx GmbH.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In 2020, if the Euro had weakened/strengthened&#13;by 10% against the U.S. dollar with all other variables held constant, the Group&amp;#8217;s loss would have been &amp;#8364;3 million&#13;higher/&amp;#8364;3 million lower, mainly as a result of foreign exchange on translation of U.S. dollar-denominated assets of InflaRx&#13;GmbH.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 70%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Cash, cash equivalents and financial assets denominated in USD of InflaRx GmbH&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Current financial assets (securities and accrued interest)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,333,240&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;32,947,491&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;22,530,687&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;4,123,532&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total assets exposed to the risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;30,863,927&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;37,071,023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Conversion rate EUR/USD at reporting date 1/1.2271&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;br style="clear: both" /&gt;&#13;&lt;/font&gt;Sensitivity analysis:&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Conversion&#13;        rate&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Profit/(loss)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;carrying&#13;        amount&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Euro weakens against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.2500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(2,805,812)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28,058,115&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Euro strengths against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.0500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,429,325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;34,293,252&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Based on the exchange rate fluctuations&#13;from the last three years, the Company expects that exchange rate fluctuations of the Euro to the U.S. dollar between 1.0500 and&#13;1.2500 could be reasonably possible. Compared to the exchange rate on the statement of financial position date (EUR/USD at reporting&#13;date is 1/1.2271), these rates could have a material impact on the Company&amp;#8217;s total loss of the period.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;5.1..3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Credit risk&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Credit risk is the risk that a counterparty&#13;will not meet its obligations leading to a financial loss for the Company. The Company is exposed to credit risk mainly from its&#13;financing activities, including deposits with banks and financial institutions, foreign exchange transactions and other financial&#13;instruments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Credit risk from balances with banks&#13;and financial institutions is managed by the Company in accordance with the Company&amp;#8217;s investment policy. Investment of financial&#13;resources which are currently not used to fund R&amp;#38;D or G&amp;#38;A activities, are made only with counterparties within the credit&#13;limits approved by the investment policy. For short-term investments in Euro or USD debt securities, a AAA credit rating is required.&#13;Only for short-term deposits in cash and cash equivalents with the Company&amp;#8217;s principal banks, their lower credit ratings&#13;are accepted (credit ratings varying between A and BBB). Complex financial products as well as other investments denominated in&#13;currencies other than USD or Euro are not permitted by the investment policy. Counterparty credit limits and the investment policy&#13;are discussed with the Company&amp;#8217;s Audit Committee on an annual basis and may be updated throughout the year subject to approval&#13;of the Company&amp;#8217;s Audit Committee. The limits are set to minimize the concentration of risks and therefore mitigate financial&#13;loss through a counterparty&amp;#8217;s potential failure to make payments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The maximum exposure to counterparty&#13;credit risk is &amp;#8364;81.4 million at December 31, 2020 (December 31, 2019: &amp;#8364;115.8 million). This amount equals the carrying&#13;amount at year end of cash and cash equivalents (2020: &amp;#8364;26.0 million; 2019: &amp;#8364;33.1 million) and financial assets (2020:&#13;&amp;#8364;55.4 million; 2019: &amp;#8364;82.6 million).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;5.1..4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Liquidity risk&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company monitors its risk of a shortage&#13;of funds in every quarterly forecast as well as on an ongoing basis. The Company disclosed the maturities of its principal liabilities&#13;under &amp;#8216;6 Commitments&amp;#8217;. Prudent liquidity risk management involves maintaining sufficient cash and marketable securities&#13;and the availability of funding to meet obligations when due. The Group continually monitors its risk of a shortage of funds using&#13;short and mid-term liquidity planning. This takes into account of the expected cash flows from all activities. The management team&#13;performs regular reviews of the budget.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company has a history of significant&#13;operating losses. Management expects that the Company incurs significant and increasing losses for the foreseeable future; as the&#13;Company may not achieve or maintain profitability in the near future, it is dependent on capital contributions or other funding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In November 2017, May 2018, and July/August&#13;2020, the Group raised significant funding that it estimates will enable the Group to fund operating expenses and capital expenditure&#13;requirements for at least 24 months from December 31, 2020. The Group expects to require additional funding to continue to advance&#13;the development of product candidates. In the event regulatory approval is received and the Company implements a strategy to commercialize&#13;the products itself, the Group would require additional capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;At the end of the reporting period, the&#13;Group held the following deposits that are expected to readily generate cash inflows to meet the outstanding financial commitments.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 70%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Liquidity&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Short-term deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;24,416,767&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;27,803,153&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Cash at banks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,551,914&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,328,127&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Marketable Securities (current)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;54,752,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;81,895,377&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Other (non-current portion)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;272,268&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;272,614&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Other (current)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;409,333&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;458,491&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total funds available&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;81,402,982&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;115,757,762&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;5.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Capital management&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s policy for capital&#13;management is to ensure that it maintains its liquidity in order to finance its operating activities, future business development&#13;and meet its liabilities when due. The Group manages its capital structure primarily through equity. The Group does not have any&#13;&amp;#64257;nancial liabilities, other than trade and other payables or leasing liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;No changes were made in the objectives,&#13;policies or processes for managing capital during the year.&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:DisclosureOfCommitmentsExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;6.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Operating contracts or services&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group enters into contracts in the&#13;normal course of business with CROs and clinical sites for the conduct of clinical trials, professional consultants for expert&#13;advice and other vendors for clinical supply manufacturing or other services. These contracts can usually be terminated with 30&#13;to 180 days' notice. In addition to this minimum duration, these contracts require full payment for services already commenced.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;During 2020, the Group did not enter&#13;contracts to purchase property, plant and equipment or patents and trademarks (respectively nil in 2019).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;6.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Lease obligations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The maturity analysis of lease liabilities&#13;is disclosed in the following table:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 49%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Maturity analysis for capitalized leases&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Contractual&#13;        minimum lease obligations&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Effect&#13;        of discounting&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Lease&#13;        liabilities&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;346,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,485&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;338,516&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;231,715&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;11,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;220,525&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;577,715&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;18,675&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;559,040&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; width: 48%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Maturity analysis for all lease obligations in 2020&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Low&#13;        value leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Short-term&#13;        leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Capitalized&#13;        leases&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;352,261&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,261&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;346,000&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;249,199&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,484&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;231,715&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;601,460&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;23,745&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;577,715&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Anticipated future lease expenses were&#13;converted with the exchange rate as of December 31, 2020, 1 Euro = 1.2271 USD.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies the &amp;#8216;lease of&#13;low-value assets&amp;#8217; recognition exemptions. The Group also applied the &amp;#8216;short-term lease&amp;#8217; exemption for leases&#13;with a maturity of less than 12 months.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; width: 48%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Maturity analysis for all lease obligations in 2019&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Low&#13;        value leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Short-term&#13;        leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Capitalized&#13;        leases&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;371,105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,387&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;10,841&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;354,878&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;532,845&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,779&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20,005&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;500,062&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;903,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;18,166&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;30,845&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;854,940&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Anticipated future lease expenses were converted with the exchange&#13;rate as of December 31, 2019, 1 Euro = 1.1234 USD.&lt;/p&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <ifrs-full:DisclosureOfNotesAndOtherExplanatoryInformationExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;7.1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Segment reporting&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has one Segment. The Group&#13;is a clinical-stage biopharmaceutical group focused on applying its proprietary anti-C5a technology. These activities are conducted&#13;as own project development. The Board of Directors is the chief operating decision maker. Management of resources and reporting&#13;to the decision maker is based on the Group as a whole.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All operational activities are conducted&#13;in Germany and the United States. No revenues were generated in 2020, 2019 and 2018. The geographic location of the Group&amp;#8217;s&#13;non-current assets are as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;December 31, 2020: &amp;#8364;1,712 thousand in Germany and &amp;#8364;219 thousand in the United States,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;December 31, 2019: &amp;#8364;2,217 thousand in Germany and &amp;#8364;374 thousand in the United States.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;None of the non-current assets are in&#13;the country where the Company is incorporated (the Netherlands).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;7.2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Related party transactions&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The compensation of the Group&amp;#8217;s&#13;executive management comprises the following for the twelve months ending December 31:&amp;#9;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 55%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Board Compensation&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Executive Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,995,292&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,793,529&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,524,202&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,139,286&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;5,218,324&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;9,801,454&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;3,134,578&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,011,853&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,325,656&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Non-executive Board of Directors&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;283,127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;269,031&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;238,180&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;69,938&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;710,611&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,085,917&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;353,065&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;979,642&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,324,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total Compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;3,487,643&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,991,495&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;13,649,754&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Executive Management comprises Executive&#13;Directors of the Board and members from the C-Level of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The table above discloses short-term&#13;employee benefits that were contractually agreed for the board and executive management. As of December 31, 2020, &amp;#8364;1,152,416&#13;were not paid but accrued (2019: &amp;#8364;868,848) for executive management and &amp;#8364;209,990 (2019: &amp;#8364;103,040) for non-executive&#13;members of the Board of Directors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Remuneration of the Group&amp;#8217;s executive&#13;management comprises fixed and variable components and share-based payment awards. In addition, executive management receive supplementary&#13;benefits and allowances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company entered into indemnification&#13;agreements with its directors and senior management. The indemnification agreements and the Company&amp;#8217;s Articles of Association&#13;require the Company to indemnify its directors to the fullest extent permitted by law.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company&amp;#8217;s current and future&#13;directors (and such other officer or employee as designated by the board of directors) have the benefit of indemnification provisions&#13;in the Articles of Association of InflaRx N.V. These provisions give the indemnified persons the right to recover from us amounts,&#13;including, but not limited to, litigation expenses, and any damages they are ordered to pay, in relation to acts or omissions in&#13;the performance of their duties. However, there is no entitlement to indemnification for acts or omissions which are considered&#13;to constitute malice, gross negligence, intentional recklessness and/or serious culpability attributable to such indemnified person.&#13;These agreements also provide, subject to certain exceptions, for indemnification for related expenses including, among others,&#13;attorneys&amp;#8217; fees, judgements, penalties, fines and settlement amounts incurred by any of these individuals in any action or&#13;proceeding. In addition to such indemnification, the Company provides its directors with directors&amp;#8217; and officers&amp;#8217; liability&#13;insurance.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;7.3.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;COVID-19 Pandemic&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The COVID-19 pandemic, which began in&#13;December 2019 has spread worldwide and continues to cause many governments to maintain measures to slow the spread of the outbreak&#13;through quarantines, travel restrictions, closure of borders and requiring maintenance of physical distance between individuals.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"&gt;Since the second quarter of 2020 the Company&amp;#8217;s&#13;employees have been able to work from their home offices or return to the Company&amp;#8217;s offices. The Company&amp;#8217;s service&#13;providers also resumed full operations in the second quarter of 2020. As the Company is currently devoting significant resources&#13;to the development of a severe COVID-19 therapy, which is currently recruiting patients in the Phase III part of a randomized,&#13;double-blind, placebo-controlled Phase II/III study, such development may impair the ability to timely progress other product candidates&#13;in clinical trials. In addition, enrollment in other programs may be delayed as a result of the COVID-19 pandemic. However, the&#13;recruitment of patients and opening of new clinical trial sites continued in the third and fourth quarter of 2020. We have taken&#13;measures to counter the negative impact of the pandemic with respect to recruitment speed, including opening of additional sites&#13;in different countries. &lt;font style="letter-spacing: 0.2pt"&gt;The rapid development and fluidity of the situation presents uncertainty&#13;and risk with respect to the Company, its performance and its financial results.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 21.3pt"&gt;&lt;font style="font-size: 8pt"&gt;7.4.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Significant events after the reporting date&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;7.4..1.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;At the Market Transaction - Offering of Common Shares&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Following December 31, 2020, the Company&#13;issued, under its at-the-market program (refer to Note 4 &amp;#8220;Issued capital&amp;#34;), 610,022 common shares resulting in &amp;#8364;2.8&#13;million in net proceeds to the Company. Following these issuances, the remaining value authorized for sale under the Sales Agreement&#13;was $35.2 million.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;7.4..2.&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Issue of common shares and accompanying warrants&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On February 25, 2021, the Company sold&#13;an aggregate of 15,000,000 common shares through a public offering. The common shares were sold at a price of $5.00 per share and&#13;have a nominal value of &amp;#8364;0.12 per share. For each common share purchased, an investor also received a warrant to purchase&#13;a common share at an exercise price of $5.80. The warrants are exercisable immediately and have a term of up to one year. The shares&#13;were issued and the transaction closed on March 1, 2021 with gross offering proceeds to the Group from this offering being $75.0&#13;million (&amp;#8364;62.2 million), before deducting $4.5 million (&amp;#8364;3.7 million) in underwriting discounts and other offering&#13;expenses of $0.5 million (&amp;#8364;0.5 million) and excluding the exercise of any warrants. The aforementioned Euro amounts were&#13;calculated using the exchange rate as of March 1, 2021 (1 USD = 0.8297 EUR).&lt;/p&gt;</ifrs-full:DisclosureOfNotesAndOtherExplanatoryInformationExplanatory>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The below listed amendments and interpretations&#13;apply for the first time in 2020, but do not have a material impact on the consolidated financial statements of the Group:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Conceptual Framework Amendments, References to the Conceptual Framework in IFRS Standards (IFRS&#13;2 Share-Based Payment, IFRS 3 Business Combinations, IAS 1 Presentation of Financial Statements, IAS 8 Accounting Policies, IAS&#13;34 Interim Financial Reporting, IAS 37 Provisions, Contingent Liabilities and Contingent Assets, IFRIC 12 Service Concession Arrangements,&#13;IFRIC 19 Extinguishing Financial Liabilities with Equity Instruments IFRIC&amp;#160;22 Foreign Currency Transactions and Advance Consideration,&#13;SIC 32 Intangible Assets &amp;#8212; Web Site Costs,), effective as of January 1, 2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 3 Business Combinations, Definition of a business, effective January 1, 2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IAS 39 Financial Instruments: Recognition and Measurement, IFRS 7 Financial Instruments Disclosures,&#13;IFRS 9 Financial Instruments, Interest Rate Benchmark Reform &amp;#8212; Phase 1, effective January 1, 2020,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IAS 1 Presentation of Financial Statements, IAS 8 Accounting Policies, Definition of Material,&#13;as of January 1, 2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <IFRX:DescriptionOfAccountingPolicyNewStandardsNotYetAdoptedExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following amendments will be adopted&#13;effective January 1, 2021 and are not expected to have a material impact on the consolidated financial statements of the Group:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Interest Rate Benchmark Reform &amp;#8212; Phase 2, Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and&#13;IFRS 16&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;COVID-19-related Rent Concessions, Amendment to IFRS 16&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following standards issued will be&#13;adopted in a future period and the potential impact, if any, they will have on the Group&amp;#8217;s consolidated financial statements&#13;is being assessed:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IFRS 4 Insurance Contracts&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 17 Insurance Contracts, including Amendments to IFRS 17&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current&#13;or Non-current and Classification of Liabilities as Current or Non-current&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IFRS 3 Business Combinations; IAS 16 Property, Plant and Equipment; IAS 37 Provisions,&#13;Contingent Liabilities and Contingent Assets; Annual Improvements 2018-2020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2: Disclosure&#13;of Accounting policies&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IAS 8 Accounting policies, Changes in Accounting Estimates and Errors: Definition&#13;of Accounting Estimates&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</IFRX:DescriptionOfAccountingPolicyNewStandardsNotYetAdoptedExplanatory>
    <IFRX:DescriptionOfAccountingPolicyCurrentAndNoncurrentClassificationExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group presents assets and liabilities&#13;in the statement of financial position based on current/non-current classification.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current assets include assets that are&#13;sold, consumed or realized as part of the normal operating cycle (operating cycle is assumed to be 12 months), or cash and cash&#13;equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting&#13;period. All other assets are classified as non-current.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current liabilities, such as trade payables,&#13;lease liabilities or employee benefits with a term of up to 12 months, and payables for operating costs or social security charges,&#13;are part of the working capital used in the Company&amp;#8217;s normal operating cycle. Such operating items are classified as current&#13;liabilities even if they are due to be settled more than 12 months after the reporting period. All other liabilities are classified&#13;as non-current.&lt;/p&gt;</IFRX:DescriptionOfAccountingPolicyCurrentAndNoncurrentClassificationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Transactions in a foreign currency are&#13;initially translated into the respective functional currency using the spot rate prevailing on the dates of the transaction. Monetary&#13;items which are not denominated in the functional currency are subsequently translated using the rate applicable at the end of&#13;the period. The resulting currency gains and losses are recognized directly in profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On consolidation, the assets and liabilities&#13;of operations in a currency other than Euro (the presentation currency of the Company&amp;#8217;s) are translated into Euros at the&#13;rate of exchange prevailing at the reporting date and their statements of operations are translated with monthly average exchange&#13;rates during the reporting period. The exchange differences arising on translation for consolidation are recognized in other comprehensive&#13;income (OCI). On disposal of a foreign operation, the component of OCI relating to that particular foreign operation is reclassified&#13;to profit or loss. OCI is disclosed as &amp;#8216;other components of equity&amp;#8217; in consolidated statements of financial position.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <IFRX:NotesToTheCashFlowStatement contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated statements of cash flows&#13;have been prepared using the indirect method for cash flows from operating activities. The cash disclosed in the consolidated statements&#13;of cash flows is comprised of cash and cash equivalents. Cash comprises cash on hand and demand deposits. Cash equivalents are&#13;short-term bank deposits that are readily convertible to a known amount of cash and are not subject to a significant risk of changes&#13;in value with an original maturity of three month or less. Interest paid and received is included in the cash from operating activities.&lt;/p&gt;</IFRX:NotesToTheCashFlowStatement>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Research and development expenses comprise&#13;third party services, wages and salaries, cost of materials, intellectual property related expenses, depreciation and amortization&#13;of relevant equipment and intangibles as well as overhead. Research and development expenses mainly consist of costs for clinical&#13;trials and manufacturing of the Company&amp;#8217;s clinical drug product; additionally, costs are incurred for pre-clinical activities&#13;as well as basic research activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Development expenses must be capitalized&#13;if the criteria of IAS 38 are met. In the periods presented, no development expenses were capitalized because management does not&#13;believe all the recognition criteria of IAS 38 had been met. This assessment is due to the general uncertainties in drug development&#13;and the unpredictability of regulatory requirements. Therefore, research expenditure and development expenditures are expensed&#13;when incurred.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Liabilities for wages and salaries and&#13;cash bonuses are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as&#13;employee benefits in the consolidated statements of financial position. A liability is recognized, if the Group has a present legal&#13;or constructive obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated&#13;reliably.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Share-based payment transactions &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The grant-date fair value of equity-settled&#13;share-based payment arrangements granted to employees is generally recognized as an expense, with a corresponding increase in equity,&#13;over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which&#13;the related service conditions are expected to be met, including an estimate of forfeitures, such that the amount ultimately recognized&#13;is based on the number of awards that meet the related service conditions at the vesting date. For share-based payment awards with&#13;immediate vesting, the grant-date fair value of the share-based payment is measured to reflect such conditions and there is no&#13;gain or loss recognized for differences between expected and actual outcomes.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group leases various properties,&#13;laboratory and office equipment and cars. Rental contracts are typically made for fixed periods of one to three years but may have&#13;renewal options. The lease agreements do not impose any covenants, but leased assets may not be used as collateral for borrowing&#13;purposes. The Group applied IFRS 16 Leases for the first time starting January 1, 2019, previous periods were not adjusted retrospectively.&#13;See Note 4.4 for the effect of this change on amounts recognized in profit or loss. Before the adoption of IFRS 16, the Group classified&#13;each of its leases (as lessee) at the inception date as either a finance lease or an operating lease. A lease was classified as&#13;a finance lease if it transferred substantially all of the risks and rewards incidental to ownership of the leased asset to the&#13;Group; otherwise it was classified as an operating lease. Before January 1, 2019, the Group did not identify any finance leases.&#13;For an operating lease, the leased property was not capitalized, and the lease payments were recognized as rent expense in profit&#13;or loss on a straight-line basis over the lease term. Any prepaid rent and accrued rent were recognized under prepayments and trade&#13;and other payables, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Set forth below are the accounting policies&#13;of the Group applied under IFRS 16 after its first-time adoption effective January 1, 2019.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Right-of-use assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group recognizes right-of-use assets&#13;at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured&#13;at cost, less any accumulated depreciation and impairment losses, and adjusted for any re-measurement of lease liabilities. The&#13;cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments&#13;made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership&#13;of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over&#13;the shorter of its estimated useful life and the lease term. On December 31, 2020, the remaining useful lives of the Company&amp;#8217;s&#13;right-of-use assets range between four and 33 months. Right-of-use assets are subject to impairment.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Lease liabilities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;At the commencement date of the lease,&#13;the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease&#13;payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments&#13;which depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include&#13;the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating&#13;a lease, if the lease term reflects the Group exercising the option to terminate. The variable lease payments that do not depend&#13;on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In calculating the present value of lease&#13;payments, the Group uses the incremental borrowing rate at the lease commencement date, since the interest rate implicit in the&#13;lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion&#13;of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is re-measured if there&#13;is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment&#13;to purchase the underlying asset.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Short-term leases and leases of low-value assets&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies the short-term lease&#13;recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months&#13;or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition&#13;exemption to leases of office equipment that are considered of low value. Lease payments on short-term leases and leases of low-value&#13;assets are recognized as expense on a straight-line basis over the lease term.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Determining the lease term of contracts &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;After the commencement date, the Group&#13;reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its&#13;ability to exercise the option to renew.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group further determines the lease&#13;term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably&#13;certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The leases which currently also result&#13;in the capitalization of a right of use asset, do not include any renewal options. For future lease contracts with potential renewal&#13;options the Company applies judgement in evaluating whether it is reasonably certain to exercise the option to renew. In doing&#13;so, management would consider all relevant factors that create an economic incentive for it to exercise the renewal.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Interest income is derived from interest-bearing&#13;financial assets, including cash equivalents. Interest income on cash and cash equivalents, financial assets at amortized cost&#13;calculated using the effective interest rate method is recognized in the consolidated statements of operations and comprehensive&#13;loss as part of finance income.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Intangible assets mainly comprise purchased&#13;IT software. Intangible assets are initially measured at acquisition cost, including any directly attributable costs of preparing&#13;the asset for its intended use less accumulated amortization and accumulated impairment losses, if any. Amortization begins when&#13;an asset is available for use and amortization is calculated using the straight-line method to allocate cost over the estimated&#13;useful lives. Software is amortized over three years. The useful lives of intangible assets are reviewed at each reporting date.&#13;The effect of any adjustment to useful lives is recognized prospectively as a change of accounting estimate. The Group only owns&#13;intangible assets with a definite useful life.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Laboratory and office equipment are stated&#13;at historical cost less accumulated depreciation and accumulated impairment losses, if any. Historical cost includes expenditure&#13;that is directly attributable to the acquisition of the items.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All repairs and maintenance are recognized&#13;in profit or loss during the financial period in which they are incurred, because they do not constitute a separate asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Depreciation on laboratory and office&#13;equipment is calculated using the straight-line method to allocate their cost over their estimated useful lives, as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Laboratory equipment: three to 13 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Office equipment: one to five years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The assets&amp;#8217; residual values and&#13;useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Gains and losses on disposals are determined&#13;by comparing the proceeds with the carrying amount and are recognized within &amp;#8216;other income&amp;#8217; or &amp;#8216;other expenses&amp;#8217;&#13;in the consolidated statements of operations and comprehensive loss.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Definition&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A financial instrument is any contract&#13;that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity. The Group&amp;#8217;s&#13;financial assets include predominantly quoted fixed-interest debt securities. The financial liabilities comprise trade and other&#13;payables (incl. accrued liabilities from the R&amp;#38;D projects).&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Criteria for the recognition and derecognition, initial measurement&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In general purchases or sales of financial&#13;assets are recognized on the settlement date, i.e., the date that the Group renders or receives the counter performance (typically&#13;cash). The Group initially measures a financial asset at its fair value plus transaction costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group initially recognizes non-derivative&#13;financial liabilities on the date that they are originated at fair value net of directly attributable transaction costs. The Group&#13;derecognizes a financial liability when its contractual obligations are discharged, cancelled, or expire.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Subsequent measurement method&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Considering the Group&amp;#8217;s business&#13;model for managing the financial assets, whose objective is to hold them in order to collect contractual cash flows, and their&#13;contractual cash flow characteristics, that are solely payments of principal and interest on the principal amount outstanding,&#13;the Group classifies the quoted debt securities with fixed interest rates as subsequently measured at amortized cost using the&#13;effective interest method (EIR). The financial assets are also subject to impairment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s financial liabilities&#13;are classified as subsequently measured at amortized cost which is calculated by considering any discount or premium on acquisition&#13;and fees or costs that are an integral part of the EIR.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;An analysis of the carrying amounts from&#13;the consolidated statements of financial position by measurement category is disclosed under &amp;#8216;under &amp;#8216;4.7 Financial&#13;assets and financial liabilities.&amp;#8217;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Criteria for realization of income and expenses&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Interest income is accrued using the&#13;relevant effective interest rate. Interest expense on liabilities, if any, is also accrued based on the effective interest rate.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Gains and losses on the disposal of financial&#13;instruments are recognized in full when all significant risks and rewards have been transferred. In the case of a partial transfer&#13;of risks and rewards, a distinction would be made as to whether control remains with the company or is transferred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Impairment losses on financial assets&#13;are recognized in profit or loss. The Group recognizes an allowance for expected credit losses (ECLs) for the financial assets&#13;held, see Note &amp;#8216;3.4 Net Financial Result&amp;#8217;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;ECLs are based on the difference between&#13;the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted&#13;at an approximation of the original effective interest rate. ECLs are generally recognized in two stages. For credit exposures&#13;for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses&#13;that result from default events that are possible within the next 12-months (a 12-month ECL). For those credit exposures for which&#13;there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses&#13;expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL). For the quoted debt&#13;securities with fixed interest rates, which have high credit ratings and no significant increases in credit risk since initial&#13;recognition, the Group determines the exposure to credit default using CDS pricing information (i.e. credit default swap values)&#13;published by credit agencies and recognizes a 12-month ECL.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group does not measure any financial&#13;asset or liability at fair value. The carrying amount of all financial instruments approximates their fair value, with the exception&#13;of quoted debt securities which fair values are disclosed (see &amp;#8216;4.7 Financial assets and financial liabilities&amp;#8217;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;When measuring the fair value of an asset&#13;or a liability, the Group would use observable market data as far as possible. Fair values are categorized into different levels&#13;in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 1, quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 2, inputs other than quoted prices included within Level 1 that are observable for the instrument,&#13;either directly (as prices) or indirectly (derived from prices).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 3, inputs for instruments that are not based on observable market data (unobservable inputs).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;If the inputs used to measure the fair&#13;value of an asset or a liability fall into different levels of the fair value hierarchy, then the fair value measurement is categorized&#13;in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group would recognize transfers between&#13;levels of the fair value hierarchy at the end of the reporting period during which the change has occurred.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Income taxes comprise current and deferred&#13;taxes. Current and deferred taxes are recognized in profit or loss except to the extent that they relate to items recognized directly&#13;in equity or in other comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Current income tax&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current income tax assets and liabilities&#13;are measured at the amount expected to be recovered from or paid to the taxation authorities. Expected tax payable or receivable&#13;on the taxable income or loss for the year, are calculated using tax rates enacted or substantively enacted at the reporting date,&#13;and any adjustment to tax payable in respect of previous years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the periods presented; the Group did&#13;not incur income tax expense. Taxes withheld by banks and remitted to tax authorities were reimbursed after filing of the annual&#13;tax declaration.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Deferred income tax&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is recognized in respect&#13;of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts&#13;used for taxation purposes. Deferred tax is not recognized for temporary differences associated with assets and liabilities if&#13;the transaction which led to their initial recognition is a transaction that is not a business combination and that affects neither&#13;accounting nor tax profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is measured at the tax rates&#13;that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively&#13;enacted by the reporting date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax assets arising from tax&#13;loss carryforwards are recognized only to the extent that the Group has sufficient taxable temporary differences or there is convincing&#13;evidence that sufficient future taxable profit will be available against which the unused tax losses can be utilized. As of December&#13;31, 2020 and 2019, based on management&amp;#8217;s judgment, it was not probable that taxable profit will be available against which&#13;the unused tax losses can be utilized; no deferred tax assets were therefore recognized in the consolidated statements of financial&#13;position.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <IFRX:SummaryOfResearchAndDevelopmentExpensesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Research and development expenses&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Third-party services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;19,886,693&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;36,783,223&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,909,366&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;manufacturing of clinical material&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;3,075,347&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;13,479,235&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;4,828,534&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;clinical, pre-clinical&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;16,811,346&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;23,303,988&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;11,080,832&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Employee benefits expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,480,890&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,231,812&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,037,082&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Equity-settled share-based payment expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;626,833&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;2,580,983&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;5,256,194&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;862,364&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;668,676&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;421,041&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;454,193&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;898,425&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;661,065&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;25,684,140&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;44,582,136&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;25,028,554&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfResearchAndDevelopmentExpensesTableTextBlock>
    <IFRX:SummaryOfGeneralAndAdministrativeExpensesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;General and administrative expenses&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Employee benefits expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,880,349&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,534,073&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,146,955&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;Equity-settled share-based payment expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;489,958&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;4,251,227&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;6,828,457&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,603,711&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,199,640&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,020,447&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Insurance expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,311,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,035&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;368,339&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation &amp;#38; amortization expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;556,456&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;503,683&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;115,330&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Compensation expense for non-executive board directors&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;283,128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;269,030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;238,180&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;831,769&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,358,587&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;897,618&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,467,203&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,501,048&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,786,869&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfGeneralAndAdministrativeExpensesTableTextBlock>
    <IFRX:SummaryOfEmployeeBenefitsExpenseTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Employee benefits expenses&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Wages and salaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,270,757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,974,807&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,501,840&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Social Security contributions (employer's share)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;551,804&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;562,255&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;350,024&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Equity-settled share-based payment expenses (see Note 3.6 Share-based payments)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,116,791&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,832,210&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,084,651&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;421,887&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;396,613&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;247,522&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,361,239&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;13,765,885&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;17,184,037&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfEmployeeBenefitsExpenseTableTextBlock>
    <IFRX:SummaryOfFinanceCostsNetTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Finance Result&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;887,702&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,840,676&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,842&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Finance expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(18,689)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(9,500)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest on lease liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(7,311)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(12,765)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;861,702&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,818,411&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,182,842&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfFinanceCostsNetTableTextBlock>
    <IFRX:SummaryOfForeignExchangeResultTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 55%; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Foreign exchange result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Foreign exchange result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,656,922&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,379,644&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,249,853&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(4,433,435)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(2,684,700)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(2,623,782)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(776,513)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;694,944&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;5,626,071&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfForeignExchangeResultTableTextBlock>
    <IFRX:SummaryOfOtherFinancialResultTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 55%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Other financial result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(126,000)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(107,182)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfOtherFinancialResultTableTextBlock>
    <IFRX:SummaryOfSharebasedPaymentsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the course of its historical financing&#13;rounds prior to 2016, InflaRx GmbH established equity-settled share-based payment programs. Those InflaRx GmbH options were converted&#13;into options for common shares of InflaRx N.V. in November 2017:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 41%; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;148,433&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;289,309&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercised during the year (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(140,876)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;148,433&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;148,433&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at December 31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;148,433&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;148,433&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.01&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 1.85pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;* Weighted average share price (WAEP) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Under the terms and conditions&#13;of the share option plan of 2016 (the &amp;#8220;2016 Plan&amp;#8221;), InflaRx GmbH granted rights to subscribe for InflaRx GmbH&amp;#8217;s&#13;common shares to directors, senior management, and key employees. Those InflaRx GmbH options were converted into options for common&#13;shares of InflaRx N.V. in November 2017:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 40%; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;1,181,484&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;1,181,484&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;7,81&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercised during the year (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(86,632)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.94&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,094,852&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,181,484&#13;        &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.98&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at December 31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,094,852&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,181,484 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;$3.35/&amp;#8364;2.98&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 16.05pt; text-indent: -14.2pt"&gt;&lt;font style="font-size: 8pt"&gt;* conversion rates used for one &amp;#8364;: December 31, 2020 $0.8149, average rate 2020 $0.8762, January 1, 2020/December 31, 2019 $0.8902, average rate 2019 $0.8932&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 55.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In conjunction with the closing of its&#13;initial public offering, InflaRx N.V. established a new incentive plan (the &amp;#8220;2017 Long-Term Incentive Plan&amp;#8221;). The initial&#13;maximum number of common shares available for issuance under equity incentive awards granted pursuant to the 2017 Long-Term Incentive&#13;Plan equals 2,341,097 common shares:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 40%; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Options&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;WAEP*&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2,181,105&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.44 /&amp;#8364;3.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2,051,009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.61/&amp;#8364;3.16 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Granted during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;246,188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$4.83 /&amp;#8364;4.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;242,450 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.25/&amp;#8364;2.91 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercised during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(78,342)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.35 /&amp;#8364;2.94&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Forfeited during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(202,473)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.61 /&amp;#8364;3.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(112.354)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$6.17/&amp;#8364;5.51 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,146,478&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.59 /&amp;#8364;2.93&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,181,105&#13;        &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.44/&amp;#8364;3.06 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at December 31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,863,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.46 /&amp;#8364;2.82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,319,548 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$3.52/&amp;#8364;3.13 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 8.95pt; text-indent: -7.1pt"&gt;&lt;font style="font-size: 8pt"&gt;* conversion rates used for one &amp;#8364;: December 31, 2020 $0.8149, average rate 2020 $0.8762, January 1, 2020/December 31, 2019 $0.8902, average rate 2019 $0.8932&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfSharebasedPaymentsTableTextBlock>
    <IFRX:SummaryOfStockOptionsGrantedTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 19%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Share options granted&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair value per &lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;option&lt;/b&gt;&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;FX rate&#13;        as of grant date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair value per &lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;option&lt;/b&gt;&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Share price at grant date / &lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Exercise price&lt;/b&gt;&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Expected&#13;        volatility&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Expected life&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;(midpoint based)&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Risk-free rate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;(interpolated, U.S. sovereign strips curve)&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;January 1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$14.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;12.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$26.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;3,00%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;February 4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;18,450&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$18.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;15.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$32.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2,60%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;May, 14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;36,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$22.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.89&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;20.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$41.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2.30%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Repricing, July 3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$0.46-$1.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.89&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;0.40-&amp;#8364;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2.3-4.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;2.30%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;October 24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$1.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;1.76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$2.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1,65%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;December 16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;38,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;2.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1,79%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;December 16*&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;2.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1,79%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-top: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; border-bottom: Black 1.5pt double"&gt;&lt;b&gt;242,450&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td colspan="9" style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;* Options granted to the executive management&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;September 18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;71,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;3.52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;4.8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.36%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;September 18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;25,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;3.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;5.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.39%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;October 1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$3.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8364;3.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;$4.28/$4.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;1.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;5.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;0.36%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-top: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; border-bottom: Black 1.5pt double"&gt;&lt;b&gt;246,188&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-left: 1.5pt; text-align: center; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfStockOptionsGrantedTableTextBlock>
    <IFRX:SummaryOfPropertyAndEquipmentTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 45%; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Property&#13;        and equipment&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;&lt;div style="border-bottom: Black 0.5pt solid; padding: 0in 0in 1pt"&gt;&#13;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Advance&lt;/p&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;payments&lt;/p&gt;&#13;&lt;/div&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(in &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;995,179&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;995,179&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;259,647&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;54,338&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;313,985&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(142,400)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(142,400)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Reclassification&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;54,408&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(54,408)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,639&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;70&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,709&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,173,473&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,173,473&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;66,114&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;66,114&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(5,298)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(5,298)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(34,750)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(34,750)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,199,540&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,199,540&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Accumulated depreciation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(370,510)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(370,510)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(252,627)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(252,627)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;26,235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;26,235&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(198)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(198)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(597,101)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(597,101)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(212,733)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(212,733)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,793&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,793&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;16,764&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;16,764&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(791,277)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(791,277)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Net book value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;576,372&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;576,372&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;408,263&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;408,263&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfPropertyAndEquipmentTableTextBlock>
    <IFRX:SummaryOfRightOfUseAssetsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; width: 45%; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Cars&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(in &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;695,614&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;35,058&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;730,672&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,754&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,754&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(266,057)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(266,057)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,512&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,512&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,067,823&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;35,058&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,102,881&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,993&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,993&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(28,366)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(28,366)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(7,997)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(7,997)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,059,826&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;108,685&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,168,512&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Accumulated depreciation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(283,350)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(20,831)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(304,181)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;38,008&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;38,008&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;216&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(245,126)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(20,831)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(265,957)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(335,608)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(34,410)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(370,018)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Disposals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,880&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,277&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;6,277&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(574,457)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(47,361)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(621,818)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Net book value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;822,697&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;14,227&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;836,924&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;485,369&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;61,324&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;546,694&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfRightOfUseAssetsTableTextBlock>
    <IFRX:SummaryOfIntangibleAssetsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 45%; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Purchased&#13;        IT-software&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Advances&#13;        paid for software&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(in &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;246,351&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;109,852&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;356,204&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;84,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;251,493&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;335,942&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Reclassification&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;353,155&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(353,155)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(64)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(64)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;683,891&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,190&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;692,081&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28,075&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Reclassification&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(8,190)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(562)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(562)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;719,593&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;719,593&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Accumulated amortization&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At January 1, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(133,337)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;&amp;#8212;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;(133,337)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Amortization charge for the year*&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(106,358)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(106,358)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;14&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(239,681)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(239,681)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Amortization charge for the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(129,963)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(129,963)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;234&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(369,410)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(369,410)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Net book value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;444,210&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,190&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;452,400&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;At December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;350,184&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;350,183&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfIntangibleAssetsTableTextBlock>
    <IFRX:SummaryOfLeaseLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: left; line-height: 9pt; font-weight: bold"&gt;Lease liabilities&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As of January 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;845,948&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;730,672&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Additions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,993&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;636,754&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Derecognition&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(20,555)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(228,547)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 8.65pt; padding-left: 8.65pt; text-indent: -8.65pt"&gt;&lt;font style="font-size: 8pt"&gt;Re-payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(366,156)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(296,020)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term liability for accrued interest expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(388)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,362&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange difference&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(1,802)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,727&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As of December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;559,041&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;845,948&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 72%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfLeaseLiabilitiesTableTextBlock>
    <IFRX:SummaryOfAmountsRecognizedInProfitOrLossTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 61%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020*&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019*&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018*&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; text-align: right; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Depreciation expense of right-of-use assets (see Note 4.2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;362,137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;265,957&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest expense on lease liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,311&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,765&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Rental expense from leases&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,275&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;70,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;213,200&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 17.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;short-term leases (included in administrative expenses)&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;937&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;65,348&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 17.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;leases of low-value assets (included in administrative expenses)&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;i&gt;5,338&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;i&gt;5,103&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total amounts recognized in profit or loss&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;375,723&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;349,173&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;213,200&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 15.7pt; background-color: white"&gt;* in 2020 and 2019&#13;leases under IFRS 16, in 2018 operating leases under IAS 17&lt;br /&gt;&#13;&lt;br /&gt;&#13;&lt;/p&gt;</IFRX:SummaryOfAmountsRecognizedInProfitOrLossTableTextBlock>
    <IFRX:SummaryOfOtherAssetsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 70%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Other assets&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Non-current other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepaid expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;353,522&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;452,217&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;353,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;452,217&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Current other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepayments on research &amp;#38; development projects&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,340,643&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;698,891&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepaid expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,295,682&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,467,936&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;98,374&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;199,088&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;3,734,699&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,365,915&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;4,088,221&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;2,818,132&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfOtherAssetsTableTextBlock>
    <IFRX:SummaryOfIncomeTaxesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 55%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;InflaRx Group&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Loss for the period (accounting profit before income tax)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(33,983,614)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(53,254,817)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(29,814,634)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;28.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;29.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;29.1%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Tax benefits at tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,761,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,815,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,715,116&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Tax losses for which no deferred tax asset was recognized&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(9,761,910)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(15,815,083)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;(8,715,116)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Income tax&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfIncomeTaxesTableTextBlock>
    <IFRX:SummaryOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 70%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Financial assets and financial liabilities&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Non-current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;272,268&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;272,614&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;47,138,738&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;82,353,867&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Trade and other payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,258,133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,413,662&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock>
    <IFRX:SummaryOfCashAndCashEquivalentsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 70%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Short-term deposits&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Deposits held in U.S. dollars (3 months original maturity and less)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;22,616,767&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;27,803,153&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Deposits held in Euro (3 months original maturity and less)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,800,000&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;24,416,767&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;27,803,153&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cash at banks&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash held in Euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,189,126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,211,478&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash held in U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;362,788&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;4,116,649&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,551,914&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;5,328,127&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;25,968,681&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;33,131,280&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfCashAndCashEquivalentsTableTextBlock>
    <IFRX:SummaryOfTradeAndOtherPayablesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 70%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Trade and other Payables&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;December&#13;        31, 2019&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Accrued liabilities from R&amp;#38;D projects&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,250,654&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,274,042&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,741,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,351,100&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other accrued liabilities and payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,266,228&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;788,520&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total trade and other payables&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,258,133&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,413,662&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfTradeAndOtherPayablesTableTextBlock>
    <IFRX:SummaryOfMaturityAnalysisForCapitalizedLeasesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; width: 49%; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Maturity analysis for capitalized leases&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Contractual&#13;        minimum lease obligations&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Effect&#13;        of discounting&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Lease&#13;        liabilities&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="padding: 1pt 5.4pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;346,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,485&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;338,516&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;231,715&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;11,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;220,525&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;577,715&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;18,675&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;559,040&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfMaturityAnalysisForCapitalizedLeasesTableTextBlock>
    <IFRX:SummaryOfMaturityAnalysisForLeaseObligationsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Maturity analysis for all lease obligations in 2020&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Low&#13;        value leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Short-term&#13;        leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Capitalized&#13;        leases&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;352,261&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,261&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;346,000&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;249,199&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,484&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;231,715&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;601,460&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;23,745&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;577,715&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Maturity analysis for all lease obligations in 2019&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Total&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Low&#13;        value leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Short-term&#13;        leases&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;Capitalized&#13;        leases&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;371,105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,387&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;10,841&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;354,878&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;532,845&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,779&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20,005&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;500,062&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;903,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;18,166&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;30,845&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;854,940&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfMaturityAnalysisForLeaseObligationsTableTextBlock>
    <IFRX:SummaryOfSubsidiariesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border: Black 1pt solid; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Name&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Place of business/ country of incorporation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Functional currency&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: Black 1pt solid; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ownership interest held by the Company&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#9;2020&amp;#9;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Principal activities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 19%; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx GmbH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 16%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Germany&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 10%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;EUR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 10%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; width: 12%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; vertical-align: top; width: 33%; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Principal operating subsidiary, biopharmaceutical company&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx Pharmaceutical Inc.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;U.S.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;USD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Subsidiary for basic research&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfSubsidiariesTableTextBlock>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="From2020-01-01to2020-12-31_custom_LaboratoryEquipmentMember">3 to 13 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="From2020-01-01to2020-12-31_ifrs-full_OfficeEquipmentMember">1 to 5 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:Prepayments contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">2340643</ifrs-full:Prepayments>
    <ifrs-full:Prepayments contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">698891</ifrs-full:Prepayments>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">246188</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">242450</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentsArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-22" decimals="INF">4.23</IFRX:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentsArrangement>
    <IFRX:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentsArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="EURPShares" id="Foot-01-23" decimals="INF">2.91</IFRX:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentsArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2020-01-01to2020-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">0</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2019-01-01to2019-12-31_custom_EquitySettledShareBasedPaymentArrangementMember" unitRef="Shares" decimals="INF">140876</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">86632</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">0</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">78342</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">0</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">202473</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="From2019-01-01to2019-12-31_custom_TwoThousandSeventeenLongTermIncentivePlanMember" unitRef="Shares" decimals="INF">112354</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2019-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2020-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2019-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2020-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">1173473</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">1199540</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-597101</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-791277</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2018-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2018-12-31_custom_CostMember" unitRef="EUR" decimals="0">995179</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2018-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2018-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-370510</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">1173473</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2020-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">1199540</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2018-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">995179</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2019-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-597101</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2020-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-791277</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantEquipmentBalance contextRef="AsOf2018-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-370510</IFRX:PropertyPlantEquipmentBalance>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">-34750</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">16764</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">70</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">6709</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-198</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">-34750</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">6639</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">16764</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-198</IFRX:PropertyPlantAndEquipmentExchangeDifferences>
    <IFRX:PropertyPlantAndEquipmentReclassification contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">-54408</IFRX:PropertyPlantAndEquipmentReclassification>
    <IFRX:PropertyPlantAndEquipmentReclassification contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentReclassification>
    <IFRX:PropertyPlantAndEquipmentReclassification contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">54408</IFRX:PropertyPlantAndEquipmentReclassification>
    <IFRX:PropertyPlantEquipmentAdditions contextRef="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantEquipmentAdditions>
    <IFRX:PropertyPlantEquipmentAdditions contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">66114</IFRX:PropertyPlantEquipmentAdditions>
    <IFRX:PropertyPlantEquipmentAdditions contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">54338</IFRX:PropertyPlantEquipmentAdditions>
    <IFRX:PropertyPlantEquipmentAdditions contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">313985</IFRX:PropertyPlantEquipmentAdditions>
    <IFRX:PropertyPlantEquipmentAdditions contextRef="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">66114</IFRX:PropertyPlantEquipmentAdditions>
    <IFRX:PropertyPlantEquipmentAdditions contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">259647</IFRX:PropertyPlantEquipmentAdditions>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">212733</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">252627</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">212733</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">252627</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2020-01-01to2020-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">5298</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-1793</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">142400</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2019-01-01to2019-12-31_custom_AdvancePaymentsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-26235</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">5298</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_CostMember" unitRef="EUR" decimals="0">142400</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2020-01-01to2020-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-1793</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:PropertyPlantAndEquipmentDisposal contextRef="From2019-01-01to2019-12-31_custom_PropertyAndEquipmentMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-26235</IFRX:PropertyPlantAndEquipmentDisposal>
    <IFRX:SummaryOfCompensationOfExecutiveManagementTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; width: 55%; padding: 1pt 5.4pt 2pt; text-align: left"&gt;Board Compensation&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2020&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;(in &amp;#8364;)&lt;/td&gt;&#13;    &lt;td style="font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 5.4pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Executive Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,995,292&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,793,529&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,524,202&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,139,286&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;5,218,324&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;9,801,454&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;3,134,578&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,011,853&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;12,325,656&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Non-executive Board of Directors&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;283,127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;269,031&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;238,180&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;69,938&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;710,611&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;1,085,917&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;353,065&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;979,642&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;1,324,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total Compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;3,487,643&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;8,991,495&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="border-bottom: Black 1.5pt double; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;13,649,754&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfCompensationOfExecutiveManagementTableTextBlock>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2019-12-31_ifrs-full_BuildingsMember_custom_CostMember" unitRef="EUR" decimals="0">1067823</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2020-12-31_ifrs-full_BuildingsMember_custom_CostMember" unitRef="EUR" decimals="0">1059826</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2019-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-245126</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2020-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-574457</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">1102881</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">1168512</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-265957</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-621818</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2018-12-31_ifrs-full_BuildingsMember_custom_CostMember" unitRef="EUR" decimals="0">695614</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2018-12-31_custom_CostMember" unitRef="EUR" decimals="0">730672</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2018-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2018-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2019-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">35058</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2020-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">108685</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2019-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-20831</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2020-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-47361</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2018-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">35058</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsBalance contextRef="AsOf2018-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsBalance>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_CostMember1811524294" unitRef="EUR" decimals="0">7997</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-6277</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">7997</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-6277</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_CostMember" unitRef="EUR" decimals="0">-1512</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">-1512</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-216</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-216</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:RightofuseAssetsExchangeDifferences contextRef="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:RightofuseAssetsExchangeDifferences>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_CostMember1811524294" unitRef="EUR" decimals="0">0</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">28366</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-7880</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_CostMember" unitRef="EUR" decimals="0">266057</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">266057</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-38008</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="EUR" decimals="0">-38008</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">28366</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">-7880</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">0</IFRX:DisposalsOfRightofuseAssets>
    <IFRX:DisposalsOfRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_DepreciationMember" unitRef="EUR" decimals="0">0</IFRX:DisposalsOfRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_BuildingsMember_custom_CostMember1811524294" unitRef="EUR" decimals="0">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="From2020-01-01to2020-12-31_custom_CostMember" unitRef="EUR" decimals="0">101993</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_BuildingsMember_custom_CostMember" unitRef="EUR" decimals="0">636754</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="From2019-01-01to2019-12-31_custom_CostMember" unitRef="EUR" decimals="0">636754</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="From2020-01-01to2020-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">101993</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="From2019-01-01to2019-12-31_ifrs-full_VehiclesMember_custom_CostMember" unitRef="EUR" decimals="0">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:LeaseLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">559041</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">845948</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="AsOf2018-12-31" unitRef="EUR" decimals="0">730672</ifrs-full:LeaseLiabilities>
    <IFRX:LeaseLiabilityForeignExchangeDifference contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-1802</IFRX:LeaseLiabilityForeignExchangeDifference>
    <IFRX:LeaseLiabilityForeignExchangeDifference contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">1727</IFRX:LeaseLiabilityForeignExchangeDifference>
    <IFRX:ShortTermLiabilityForAccruedInterestExpense contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-388</IFRX:ShortTermLiabilityForAccruedInterestExpense>
    <IFRX:ShortTermLiabilityForAccruedInterestExpense contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">1362</IFRX:ShortTermLiabilityForAccruedInterestExpense>
    <IFRX:RepaymentsOfLeaseLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-366156</IFRX:RepaymentsOfLeaseLiabilities>
    <IFRX:RepaymentsOfLeaseLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-296020</IFRX:RepaymentsOfLeaseLiabilities>
    <IFRX:DerecognitionOfLeaseLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">-20555</IFRX:DerecognitionOfLeaseLiabilities>
    <IFRX:DerecognitionOfLeaseLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">-228547</IFRX:DerecognitionOfLeaseLiabilities>
    <IFRX:AdditionsToLeaseLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">101993</IFRX:AdditionsToLeaseLiabilities>
    <IFRX:AdditionsToLeaseLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">636754</IFRX:AdditionsToLeaseLiabilities>
    <ifrs-full:BalancesWithBanks contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">1551914</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">5328127</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="AsOf2020-12-31_custom_USDollarMember" unitRef="EUR" decimals="0">362788</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="AsOf2019-12-31_custom_USDollarMember" unitRef="EUR" decimals="0">4116649</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="AsOf2020-12-31_custom_EuroMember" unitRef="EUR" decimals="0">1189126</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="AsOf2019-12-31_custom_EuroMember" unitRef="EUR" decimals="0">1211478</ifrs-full:BalancesWithBanks>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="From2020-01-01to2020-12-31_custom_ResearchAndDevelopmentMember" unitRef="EUR" decimals="0">27937</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="From2019-01-01to2019-12-31_custom_ResearchAndDevelopmentMember" unitRef="EUR" decimals="0">30662</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="From2020-01-01to2020-12-31_custom_GeneralAndAdministrativeMember" unitRef="EUR" decimals="0">102026</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="From2019-01-01to2019-12-31_custom_GeneralAndAdministrativeMember" unitRef="EUR" decimals="0">75696</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="From2018-01-01to2018-12-31_custom_GeneralAndAdministrativeMember" unitRef="EUR" decimals="0">19414</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="From2018-01-01to2018-12-31_custom_ResearchAndDevelopmentMember" unitRef="EUR" decimals="0">5841</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:CashOutflowForLeases contextRef="From2020-01-01to2020-12-31" unitRef="EUR" decimals="0">374698</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases contextRef="From2019-01-01to2019-12-31" unitRef="EUR" decimals="0">378035</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="0">213200</ifrs-full:CashOutflowForLeases>
    <IFRX:RiskExposure contextRef="From2020-01-01to2020-12-31_ifrs-full_MarketRiskMember">Future development costs; Recognized financial assets and liabilities not denominated in Euro</IFRX:RiskExposure>
    <IFRX:RiskExposure contextRef="From2020-01-01to2020-12-31_ifrs-full_CreditRiskMember">Cash and cash equivalents, current and non-current financial assets</IFRX:RiskExposure>
    <IFRX:RiskExposure contextRef="From2020-01-01to2020-12-31_custom_LiquidityMember">R&amp;D and G&amp;A cost, equity, trade and other payables</IFRX:RiskExposure>
    <IFRX:RiskMeasurement contextRef="From2020-01-01to2020-12-31_ifrs-full_MarketRiskMember">Forecasted cash flows Sensitivity analysis</IFRX:RiskMeasurement>
    <IFRX:RiskMeasurement contextRef="From2020-01-01to2020-12-31_ifrs-full_CreditRiskMember">Credit rating</IFRX:RiskMeasurement>
    <IFRX:RiskMeasurement contextRef="From2020-01-01to2020-12-31_custom_LiquidityMember">Rolling cash flow forecast</IFRX:RiskMeasurement>
    <IFRX:RiskManagement contextRef="From2020-01-01to2020-12-31_ifrs-full_MarketRiskMember">Achievement of a natural hedge in the future</IFRX:RiskManagement>
    <IFRX:RiskManagement contextRef="From2020-01-01to2020-12-31_ifrs-full_CreditRiskMember">Diversification of bank deposits, Investment guidelines for debt investments</IFRX:RiskManagement>
    <IFRX:RiskManagement contextRef="From2020-01-01to2020-12-31_custom_LiquidityMember">Availability of funds through financing rounds or public offerings</IFRX:RiskManagement>
    <IFRX:AssetsExposedToRisk contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">30863927</IFRX:AssetsExposedToRisk>
    <IFRX:AssetsExposedToRisk contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">37071023</IFRX:AssetsExposedToRisk>
    <IFRX:CashAndCashEquivalentsSubsidiary contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">22530687</IFRX:CashAndCashEquivalentsSubsidiary>
    <IFRX:CashAndCashEquivalentsSubsidiary contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">4123532</IFRX:CashAndCashEquivalentsSubsidiary>
    <IFRX:CurrentFinancialAssetsSubsidiary contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">8333240</IFRX:CurrentFinancialAssetsSubsidiary>
    <IFRX:CurrentFinancialAssetsSubsidiary contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">32947491</IFRX:CurrentFinancialAssetsSubsidiary>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2020-12-31_custom_EuroWeakensMember" unitRef="USDPerEUR" decimals="INF">1.2500</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2020-12-31_custom_EuroStrengthensMember" unitRef="USDPerEUR" decimals="INF">1.0500</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2020-01-01to2020-12-31_custom_EuroWeakensMember" unitRef="EUR" decimals="0">-2805812</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2020-01-01to2020-12-31_custom_EuroStrengthensMember" unitRef="EUR" decimals="0">3429325</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:Cash contextRef="AsOf2020-12-31_custom_EuroWeakensMember" unitRef="EUR" decimals="0">28058115</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2020-12-31_custom_EuroStrengthensMember" unitRef="EUR" decimals="0">34293252</ifrs-full:Cash>
    <ifrs-full:GrossLeaseLiabilities contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">559040</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">338516</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">220525</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</ifrs-full:GrossLeaseLiabilities>
    <IFRX:EffectOfDiscounting contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">18675</IFRX:EffectOfDiscounting>
    <IFRX:EffectOfDiscounting contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">7485</IFRX:EffectOfDiscounting>
    <IFRX:EffectOfDiscounting contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">11190</IFRX:EffectOfDiscounting>
    <IFRX:EffectOfDiscounting contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</IFRX:EffectOfDiscounting>
    <IFRX:ContractualMinimumLeaseObligations contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">577715</IFRX:ContractualMinimumLeaseObligations>
    <IFRX:ContractualMinimumLeaseObligations contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">346000</IFRX:ContractualMinimumLeaseObligations>
    <IFRX:ContractualMinimumLeaseObligations contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">231715</IFRX:ContractualMinimumLeaseObligations>
    <IFRX:ContractualMinimumLeaseObligations contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</IFRX:ContractualMinimumLeaseObligations>
    <IFRX:CapitalizedLease contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">577715</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">854940</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">346000</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">231715</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2019-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">354878</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2019-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">500062</IFRX:CapitalizedLease>
    <IFRX:CapitalizedLease contextRef="AsOf2019-12-31_custom_MoreThanFiveYearsMember20658484" unitRef="EUR" decimals="0">0</IFRX:CapitalizedLease>
    <IFRX:ShortTermLease contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">0</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">30845</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">0</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">0</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2019-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">10841</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2019-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">20005</IFRX:ShortTermLease>
    <IFRX:ShortTermLease contextRef="AsOf2019-12-31_custom_MoreThanFiveYearsMember20658484" unitRef="EUR" decimals="0">0</IFRX:ShortTermLease>
    <IFRX:LowValueLease contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">23745</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">18166</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">6261</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">17484</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2019-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">5387</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2019-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">12779</IFRX:LowValueLease>
    <IFRX:LowValueLease contextRef="AsOf2019-12-31_custom_MoreThanFiveYearsMember20658484" unitRef="EUR" decimals="0">0</IFRX:LowValueLease>
    <IFRX:TotalLeaseObligations contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">601460</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">903951</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2020-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">352261</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2020-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">249199</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2020-12-31_custom_MoreThanFiveYearsMember1817451038" unitRef="EUR" decimals="0">0</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2019-12-31_ifrs-full_NotLaterThanOneYearMember" unitRef="EUR" decimals="0">371105</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2019-12-31_custom_AfterOneYearButNotMoreThanFiveYearsMember" unitRef="EUR" decimals="0">532845</IFRX:TotalLeaseObligations>
    <IFRX:TotalLeaseObligations contextRef="AsOf2019-12-31_custom_MoreThanFiveYearsMember20658484" unitRef="EUR" decimals="0">0</IFRX:TotalLeaseObligations>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">28228415</dei:EntityCommonStockSharesOutstanding>
    <IFRX:FinancialAssetsCurrent contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">47138738</IFRX:FinancialAssetsCurrent>
    <IFRX:FinancialAssetsCurrent contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">82353867</IFRX:FinancialAssetsCurrent>
    <IFRX:IncomeTaxReceivableCurrent contextRef="AsOf2020-12-31" unitRef="EUR" decimals="0">1026494</IFRX:IncomeTaxReceivableCurrent>
    <IFRX:IncomeTaxReceivableCurrent contextRef="AsOf2019-12-31" unitRef="EUR" decimals="0">1134968</IFRX:IncomeTaxReceivableCurrent>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-6" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-7" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-2" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-3" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-4" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-5" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-6" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-7" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-8" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-9" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-10" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-11" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-12" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-13" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-14" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-15" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-16" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-17" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-18" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-19" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-20" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-21" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-22" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-23" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-2" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-3" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-4" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-5" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-6" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-7" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-8" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-9" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-10" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-11" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-05" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-1" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-2" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-3" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-4" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-5" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-6" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-0" xlink:label="Foot-04_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-04_loc" xlink:to="Footnote-04" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Please refer to Note 2.1 regarding certain presentational reclassifications.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">Weighted average share price (WAEP).</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Conversion rates used for one Euro: December 31, 2020 $0.8149, average rate 2020 $0.8762, January 1, 2020/December 31, 2019 $0.8902, average rate 2019 $0.8932.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">Options granted to the executive management.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-05" xml:lang="en-US">In 2020 and 2019 leases under IFRS 16, in 2018 operating leases under IAS 17.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>